Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean methylation difference in a region of the two groups being and of quotient of mean methylation levelsas well as a p-value obtained from statistical testing (limma or t-test; depending on parameter settings). Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
| tiling | cpgislands | genes | promoters | ensembleRegBuildBPall | ensembleRegBuildBPallMerged | |
| CMP vs. MEP (based on cmp_ct_CMPvMEP) | 0 | 0 | 0 | 0 | 0 | 0 |
| CMP vs. GMP (based on cmp_ct_CMPvGMP) | 0 | 0 | 0 | 0 | 0 | 0 |
| CLP vs. CMP (based on cmp_ct_CMPvCLP) | 0 | 0 | 0 | 0 | 0 | 0 |
| GMP vs. MLP3 (based on cmp_ct_MLP3vGMP) | 0 | 0 | 0 | 0 | 0 | 0 |
| CLP vs. MLP0 (based on cmp_ct_CLPvMLP0) | 0 | 0 | 0 | 0 | 0 | 0 |
| CLP vs. MLP1 (based on cmp_ct_CLPvMLP1) | 0 | 0 | 0 | 0 | 0 | 0 |
| CLP vs. MLP2 (based on cmp_ct_CLPvMLP2) | 0 | 0 | 0 | 0 | 0 | 0 |
| CLP vs. MLP3 (based on cmp_ct_CLPvMLP3) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP1 vs. MLP2 (based on cmp_ct_MLP1vMLP2) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP2 vs. MLP3 (based on cmp_ct_MLP2vMLP3) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP1 vs. MLP3 (based on cmp_ct_MLP1vMLP3) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP0 vs. MLP1 (based on cmp_ct_MLP0vMLP1) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP0 vs. MLP2 (based on cmp_ct_MLP0vMLP2) | 0 | 0 | 0 | 0 | 0 | 0 |
| MLP0 vs. MLP3 (based on cmp_ct_MLP0vMLP3) | 0 | 0 | 0 | 0 | 0 | 0 |
| HSC vs. MPP (based on cmp_ct_HSCvMPP) | 0 | 0 | 0 | 0 | 0 | 0 |
| CMP vs. MPP (based on cmp_ct_MPPvCMP) | 0 | 0 | 0 | 0 | 0 | 0 |
| HSC vs. ML (based on cmp_ct_HSCvML) | 0 | 0 | 0 | 0 | 0 | 0 |
| LYM vs. MYE (based on cmp_ct_MYEvLYM) | 0 | 0 | 0 | 0 | 0 | 0 |
| BM vs. CB (based on cmp_src_HSC_BMvCB) | 0 | 0 | 0 | 0 | 0 | 0 |
| BM vs. FL (based on cmp_src_HSC_BMvFL) | 0 | 0 | 0 | 0 | 0 | 0 |
| BM vs. PB (based on cmp_src_HSC_BMvPB) | 0 | 0 | 0 | 0 | 0 | 0 |
| CB vs. FL (based on cmp_src_HSC_CBvFL) | 0 | 0 | 0 | 0 | 0 | 0 |
| CB vs. PB (based on cmp_src_HSC_CBvPB) | 0 | 0 | 0 | 0 | 0 | 0 |
| FL vs. PB (based on cmp_src_HSC_FLvPB) | 0 | 0 | 0 | 0 | 0 | 0 |
| BM vs. CB (based on cmp_src_MPP_BMvCB) | 0 | 0 | 0 | 0 | 0 | 0 |
| BM vs. PB (based on cmp_src_MPP_BMvPB) | 0 | 0 | 0 | 0 | 0 | 0 |
| CB vs. PB (based on cmp_src_MPP_CBvPB) | 0 | 0 | 0 | 0 | 0 | 0 |
| HSC vs. MPP (based on cmp_HSCvMPP_PB) | 0 | 0 | 0 | 0 | 0 | 0 |
| HSC vs. MPP (based on cmp_HSCvMPP_CB) | 0 | 0 | 0 | 0 | 0 | 0 |
| HSC vs. MPP (based on cmp_HSCvMPP_BM) | 0 | 0 | 0 | 0 | 0 | 0 |
| comparison | |
| regions | |
| differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
Differential Methylation Tables
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
- id: region id
- Chromosome: chromosome of the region
- Start: start coordinate of the region
- End: end coordinate of the region
- mean.g1,mean.g2: (where g1 and g2 is replaced by the respective group names in the table) mean methylation in each of the two groups
- mean.diff: difference in methylation means between the two groups: mean.g1-mean.g2. In case of paired analysis, it is the mean of the pairwise differences.
- mean.quot.log2: log2 of the quotient in methylation: log2((mean.g1+epsilon)/(mean.g2+epsilon)), where epsilon:=0.01. In case of paired analysis, it is the mean of the pairwise quotients.
- diffmeth.p.val: p-value obtained from linear models employed in the limma package (or alternatively from a two-sided Welch t-test; which type of p-value is computed is specified in the differential.site.test.method option).
- max.g1,max.g2: maximum methylation level in group 1 and 2 respectively
- min.g1,min.g2: minimum methylation level in group 1 and 2 respectively
- sd.g1,sd.g2: standard deviation of methylation levels
- min.diff: Minimum of 0 and the smallest pairwise difference between samples of the two groups
- diffmeth.p.adj.fdr: FDR adjusted p-value of all sites
- combinedRank: mean.diff, mean.quot.log2 and diffmeth.p.val are ranked for all regions. This aggregates them using the maximum, i.e. worst rank of a site among the three measures
- num.na.g1,num.na.g2: number of NA methylation values for groups 1 and 2 respectively
- mean.covg.g1,mean.covg.g2: mean coverage of groups 1 and 2 respectively (In case of Infinium array methylation data, coverage is defined as combined beadcount.)
- min.covg.g1,min.covg.g2: minimum coverage of groups 1 and 2 respectively
- max.covg.g1,max.covg.g2: maximum coverage of groups 1 and 2 respectively
- covg.thresh.nsamples.g1,covg.thresh.nsamples.g2: number of samples in group 1 and 2 respectively exceeding the coverage threshold (1) for this region.
The tables for the individual comparisons can be found here:
| tiling | cpgislands | genes | promoters | ensembleRegBuildBPall | ensembleRegBuildBPallMerged | |
| CMP vs. MEP (based on cmp_ct_CMPvMEP) | csv | csv | csv | csv | csv | csv |
| CMP vs. GMP (based on cmp_ct_CMPvGMP) | csv | csv | csv | csv | csv | csv |
| CLP vs. CMP (based on cmp_ct_CMPvCLP) | csv | csv | csv | csv | csv | csv |
| GMP vs. MLP3 (based on cmp_ct_MLP3vGMP) | csv | csv | csv | csv | csv | csv |
| CLP vs. MLP0 (based on cmp_ct_CLPvMLP0) | csv | csv | csv | csv | csv | csv |
| CLP vs. MLP1 (based on cmp_ct_CLPvMLP1) | csv | csv | csv | csv | csv | csv |
| CLP vs. MLP2 (based on cmp_ct_CLPvMLP2) | csv | csv | csv | csv | csv | csv |
| CLP vs. MLP3 (based on cmp_ct_CLPvMLP3) | csv | csv | csv | csv | csv | csv |
| MLP1 vs. MLP2 (based on cmp_ct_MLP1vMLP2) | csv | csv | csv | csv | csv | csv |
| MLP2 vs. MLP3 (based on cmp_ct_MLP2vMLP3) | csv | csv | csv | csv | csv | csv |
| MLP1 vs. MLP3 (based on cmp_ct_MLP1vMLP3) | csv | csv | csv | csv | csv | csv |
| MLP0 vs. MLP1 (based on cmp_ct_MLP0vMLP1) | csv | csv | csv | csv | csv | csv |
| MLP0 vs. MLP2 (based on cmp_ct_MLP0vMLP2) | csv | csv | csv | csv | csv | csv |
| MLP0 vs. MLP3 (based on cmp_ct_MLP0vMLP3) | csv | csv | csv | csv | csv | csv |
| HSC vs. MPP (based on cmp_ct_HSCvMPP) | csv | csv | csv | csv | csv | csv |
| CMP vs. MPP (based on cmp_ct_MPPvCMP) | csv | csv | csv | csv | csv | csv |
| HSC vs. ML (based on cmp_ct_HSCvML) | csv | csv | csv | csv | csv | csv |
| LYM vs. MYE (based on cmp_ct_MYEvLYM) | csv | csv | csv | csv | csv | csv |
| BM vs. CB (based on cmp_src_HSC_BMvCB) | csv | csv | csv | csv | csv | csv |
| BM vs. FL (based on cmp_src_HSC_BMvFL) | csv | csv | csv | csv | csv | csv |
| BM vs. PB (based on cmp_src_HSC_BMvPB) | csv | csv | csv | csv | csv | csv |
| CB vs. FL (based on cmp_src_HSC_CBvFL) | csv | csv | csv | csv | csv | csv |
| CB vs. PB (based on cmp_src_HSC_CBvPB) | csv | csv | csv | csv | csv | csv |
| FL vs. PB (based on cmp_src_HSC_FLvPB) | csv | csv | csv | csv | csv | csv |
| BM vs. CB (based on cmp_src_MPP_BMvCB) | csv | csv | csv | csv | csv | csv |
| BM vs. PB (based on cmp_src_MPP_BMvPB) | csv | csv | csv | csv | csv | csv |
| CB vs. PB (based on cmp_src_MPP_CBvPB) | csv | csv | csv | csv | csv | csv |
| HSC vs. MPP (based on cmp_HSCvMPP_PB) | csv | csv | csv | csv | csv | csv |
| HSC vs. MPP (based on cmp_HSCvMPP_CB) | csv | csv | csv | csv | csv | csv |
| HSC vs. MPP (based on cmp_HSCvMPP_BM) | csv | csv | csv | csv | csv | csv |
Enrichment Analysis
Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Wordclouds for GO enrichment terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 4e-04 | 31.3263 | 0.1649 | 3 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 8e-04 | 25.5268 | 0.201 | 3 | 451 | detection of chemical stimulus |
| GO:0007606 | 8e-04 | 24.7858 | 0.2068 | 3 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 8e-04 | 24.7858 | 0.2068 | 3 | 464 | detection of stimulus involved in sensory perception |
| GO:0021542 | 0.0071 | 174.2333 | 0.0071 | 1 | 16 | dentate gyrus development |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021509 | 2e-04 | Inf | 2e-04 | 1 | 1 | roof plate formation |
| GO:2001051 | 2e-04 | Inf | 2e-04 | 1 | 1 | positive regulation of tendon cell differentiation |
| GO:0035992 | 8e-04 | 2616.1667 | 8e-04 | 1 | 4 | tendon formation |
| GO:0021527 | 0.0029 | 560.2143 | 0.0029 | 1 | 15 | spinal cord association neuron differentiation |
| GO:0048853 | 0.0032 | 490.125 | 0.0032 | 1 | 17 | forebrain morphogenesis |
| GO:0045730 | 0.0048 | 326.5833 | 0.0048 | 1 | 25 | respiratory burst |
| GO:0060571 | 0.005 | 313.5 | 0.005 | 1 | 26 | morphogenesis of an epithelial fold |
| GO:0032924 | 0.008 | 190.9634 | 0.008 | 1 | 42 | activin receptor signaling pathway |
| GO:0010862 | 0.009 | 170.1522 | 0.009 | 1 | 47 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010868 | 4e-04 | 7849.5 | 4e-04 | 1 | 2 | negative regulation of triglyceride biosynthetic process |
| GO:0032792 | 0.001 | 1962 | 0.001 | 1 | 5 | negative regulation of CREB transcription factor activity |
| GO:2000210 | 0.0013 | 1307.8333 | 0.0013 | 1 | 7 | positive regulation of anoikis |
| GO:0061088 | 0.0019 | 871.7222 | 0.0019 | 1 | 10 | regulation of sequestering of zinc ion |
| GO:0045721 | 0.0023 | 713.1364 | 0.0023 | 1 | 12 | negative regulation of gluconeogenesis |
| GO:0043153 | 0.0036 | 435.6111 | 0.0036 | 1 | 19 | entrainment of circadian clock by photoperiod |
| GO:0006882 | 0.004 | 392 | 0.004 | 1 | 21 | cellular zinc ion homeostasis |
| GO:0071577 | 0.0042 | 373.3095 | 0.0042 | 1 | 22 | zinc II ion transmembrane transport |
| GO:0090207 | 0.0065 | 237.3788 | 0.0065 | 1 | 34 | regulation of triglyceride metabolic process |
| GO:0030001 | 0.0071 | 38.621 | 0.1481 | 2 | 775 | metal ion transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035574 | 0 | 482.5538 | 0.0067 | 2 | 15 | histone H4-K20 demethylation |
| GO:0045653 | 0 | 392 | 0.008 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0006335 | 1e-04 | 208.88 | 0.0143 | 2 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0016577 | 1e-04 | 202.129 | 0.0147 | 2 | 33 | histone demethylation |
| GO:0008214 | 1e-04 | 189.8545 | 0.0156 | 2 | 35 | protein dealkylation |
| GO:0032776 | 1e-04 | 189.8545 | 0.0156 | 2 | 35 | DNA methylation on cytosine |
| GO:0051290 | 1e-04 | 174 | 0.0169 | 2 | 38 | protein heterotetramerization |
| GO:0034080 | 1e-04 | 164.8211 | 0.0178 | 2 | 40 | CENP-A containing nucleosome assembly |
| GO:0000183 | 1e-04 | 160.5846 | 0.0183 | 2 | 41 | chromatin silencing at rDNA |
| GO:1901532 | 2e-04 | 152.7317 | 0.0192 | 2 | 43 | regulation of hematopoietic progenitor cell differentiation |
| GO:0034724 | 2e-04 | 130.4 | 0.0223 | 2 | 50 | DNA replication-independent nucleosome organization |
| GO:0002548 | 3e-04 | 109.7474 | 0.0263 | 2 | 59 | monocyte chemotaxis |
| GO:0070988 | 3e-04 | 104.24 | 0.0276 | 2 | 62 | demethylation |
| GO:0006303 | 3e-04 | 99.2571 | 0.029 | 2 | 65 | double-strand break repair via nonhomologous end joining |
| GO:0043044 | 4e-04 | 90.5913 | 0.0317 | 2 | 71 | ATP-dependent chromatin remodeling |
| GO:0072676 | 5e-04 | 85.6055 | 0.0334 | 2 | 75 | lymphocyte migration |
| GO:0045815 | 5e-04 | 83.312 | 0.0343 | 2 | 77 | positive regulation of gene expression, epigenetic |
| GO:0070098 | 5e-04 | 81.1377 | 0.0352 | 2 | 79 | chemokine-mediated signaling pathway |
| GO:0030593 | 6e-04 | 74.3429 | 0.0383 | 2 | 86 | neutrophil chemotaxis |
| GO:0006305 | 6e-04 | 73.4635 | 0.0388 | 2 | 87 | DNA alkylation |
| GO:0071347 | 7e-04 | 70.9455 | 0.0401 | 2 | 90 | cellular response to interleukin-1 |
| GO:0044728 | 8e-04 | 63.6653 | 0.0446 | 2 | 100 | DNA methylation or demethylation |
| GO:0010868 | 9e-04 | 2615.8333 | 9e-04 | 1 | 2 | negative regulation of triglyceride biosynthetic process |
| GO:1902679 | 9e-04 | 16.4173 | 0.5274 | 4 | 1183 | negative regulation of RNA biosynthetic process |
| GO:0097530 | 0.001 | 57.7333 | 0.049 | 2 | 110 | granulocyte migration |
| GO:0050729 | 0.001 | 56.6764 | 0.0499 | 2 | 112 | positive regulation of inflammatory response |
| GO:0000723 | 0.0013 | 49.8272 | 0.0566 | 2 | 127 | telomere maintenance |
| GO:1903707 | 0.0014 | 48.65 | 0.058 | 2 | 130 | negative regulation of hemopoiesis |
| GO:0071346 | 0.0015 | 46.4537 | 0.0606 | 2 | 136 | cellular response to interferon-gamma |
| GO:0045934 | 0.0016 | 14.1574 | 0.604 | 4 | 1355 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0031497 | 0.0016 | 45.4277 | 0.062 | 2 | 139 | chromatin assembly |
| GO:0035556 | 0.0017 | 13.09 | 1.1242 | 5 | 2522 | intracellular signal transduction |
| GO:0031047 | 0.0018 | 42.3102 | 0.0664 | 2 | 149 | gene silencing by RNA |
| GO:0000724 | 0.0019 | 41.7369 | 0.0673 | 2 | 151 | double-strand break repair via homologous recombination |
| GO:0045814 | 0.0019 | 41.7369 | 0.0673 | 2 | 151 | negative regulation of gene expression, epigenetic |
| GO:0009890 | 0.0021 | 12.9813 | 0.6535 | 4 | 1466 | negative regulation of biosynthetic process |
| GO:0032792 | 0.0022 | 653.8333 | 0.0022 | 1 | 5 | negative regulation of CREB transcription factor activity |
| GO:0065004 | 0.0023 | 37.1952 | 0.0753 | 2 | 169 | protein-DNA complex assembly |
| GO:0070374 | 0.0023 | 37.1952 | 0.0753 | 2 | 169 | positive regulation of ERK1 and ERK2 cascade |
| GO:0045637 | 0.0026 | 34.8719 | 0.0802 | 2 | 180 | regulation of myeloid cell differentiation |
| GO:2000503 | 0.0027 | 523.0333 | 0.0027 | 1 | 6 | positive regulation of natural killer cell chemotaxis |
| GO:2000210 | 0.0031 | 435.8333 | 0.0031 | 1 | 7 | positive regulation of anoikis |
| GO:0060326 | 0.0042 | 27.3805 | 0.1016 | 2 | 228 | cell chemotaxis |
| GO:0071103 | 0.0043 | 27.0166 | 0.103 | 2 | 231 | DNA conformation change |
| GO:0071356 | 0.0051 | 24.7136 | 0.1123 | 2 | 252 | cellular response to tumor necrosis factor |
| GO:0043117 | 0.0053 | 237.6515 | 0.0053 | 1 | 12 | positive regulation of vascular permeability |
| GO:0043922 | 0.0053 | 237.6515 | 0.0053 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0045721 | 0.0053 | 237.6515 | 0.0053 | 1 | 12 | negative regulation of gluconeogenesis |
| GO:0043414 | 0.0057 | 23.2921 | 0.119 | 2 | 267 | macromolecule methylation |
| GO:0006310 | 0.0064 | 22.0229 | 0.1257 | 2 | 282 | DNA recombination |
| GO:0051252 | 0.0071 | 8.9103 | 1.5352 | 5 | 3444 | regulation of RNA metabolic process |
| GO:0000278 | 0.0075 | 11.0338 | 0.4467 | 3 | 1002 | mitotic cell cycle |
| GO:0010959 | 0.0083 | 19.1589 | 0.144 | 2 | 323 | regulation of metal ion transport |
| GO:0043153 | 0.0084 | 145.1667 | 0.0085 | 1 | 19 | entrainment of circadian clock by photoperiod |
| GO:1901623 | 0.0089 | 137.5175 | 0.0089 | 1 | 20 | regulation of lymphocyte chemotaxis |
| GO:0080090 | 0.0089 | 11.1697 | 2.4477 | 6 | 5491 | regulation of primary metabolic process |
| GO:0052472 | 0.0093 | 130.6333 | 0.0094 | 1 | 21 | modulation by host of symbiont transcription |
| GO:0031323 | 0.0097 | 10.9199 | 2.4839 | 6 | 5572 | regulation of cellular metabolic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000028 | 0.002 | 1045.7333 | 0.002 | 1 | 16 | ribosomal small subunit assembly |
| GO:0000462 | 0.0032 | 653.2083 | 0.0032 | 1 | 25 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 0 | 2010.5128 | 0.0092 | 5 | 18 | protein targeting to Golgi |
| GO:0006891 | 0 | 686.7105 | 0.0219 | 5 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0072594 | 0 | 39.7887 | 0.324 | 5 | 636 | establishment of protein localization to organelle |
| GO:0006886 | 0 | 25.4124 | 0.4947 | 5 | 971 | intracellular protein transport |
| GO:0016192 | 2e-04 | 18.5017 | 0.6633 | 5 | 1302 | vesicle-mediated transport |
| GO:0070727 | 3e-04 | 16.1767 | 0.7494 | 5 | 1471 | cellular macromolecule localization |
| GO:1902582 | 5e-04 | 14.2933 | 0.8375 | 5 | 1644 | single-organism intracellular transport |
| GO:0008104 | 0.0026 | 9.6426 | 1.1809 | 5 | 2318 | protein localization |
| GO:0071702 | 0.0037 | 8.8345 | 1.2716 | 5 | 2496 | organic substance transport |
| GO:0051649 | 0.0037 | 8.8303 | 1.2721 | 5 | 2497 | establishment of localization in cell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 0 | 2010.5128 | 0.0092 | 5 | 18 | protein targeting to Golgi |
| GO:0006891 | 0 | 686.7105 | 0.0219 | 5 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0072594 | 0 | 39.7887 | 0.324 | 5 | 636 | establishment of protein localization to organelle |
| GO:0006886 | 0 | 25.4124 | 0.4947 | 5 | 971 | intracellular protein transport |
| GO:0016192 | 2e-04 | 18.5017 | 0.6633 | 5 | 1302 | vesicle-mediated transport |
| GO:0070727 | 3e-04 | 16.1767 | 0.7494 | 5 | 1471 | cellular macromolecule localization |
| GO:1902582 | 5e-04 | 14.2933 | 0.8375 | 5 | 1644 | single-organism intracellular transport |
| GO:0008104 | 0.0026 | 9.6426 | 1.1809 | 5 | 2318 | protein localization |
| GO:0071702 | 0.0037 | 8.8345 | 1.2716 | 5 | 2496 | organic substance transport |
| GO:0051649 | 0.0037 | 8.8303 | 1.2721 | 5 | 2497 | establishment of localization in cell |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010868 | 6e-04 | 3924.25 | 6e-04 | 1 | 2 | negative regulation of triglyceride biosynthetic process |
| GO:0032792 | 0.0016 | 980.875 | 0.0016 | 1 | 5 | negative regulation of CREB transcription factor activity |
| GO:2000210 | 0.0022 | 653.8333 | 0.0022 | 1 | 7 | positive regulation of anoikis |
| GO:0030522 | 0.0033 | 35.6713 | 0.0923 | 2 | 290 | intracellular receptor signaling pathway |
| GO:0045721 | 0.0038 | 356.5227 | 0.0038 | 1 | 12 | negative regulation of gluconeogenesis |
| GO:0043153 | 0.006 | 217.7778 | 0.006 | 1 | 19 | entrainment of circadian clock by photoperiod |
| GO:0002227 | 0.007 | 186.631 | 0.007 | 1 | 22 | innate immune response in mucosa |
| GO:0048387 | 0.0092 | 139.9107 | 0.0092 | 1 | 29 | negative regulation of retinoic acid receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009386 | 5e-04 | 5232.6667 | 5e-04 | 1 | 2 | translational attenuation |
| GO:0050911 | 0.0032 | 41.6603 | 0.0942 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0000028 | 0.0041 | 348.5333 | 0.0041 | 1 | 16 | ribosomal small subunit assembly |
| GO:0009593 | 0.0048 | 33.9644 | 0.1149 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 0.005 | 32.9805 | 0.1182 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0.005 | 32.9805 | 0.1182 | 2 | 464 | detection of stimulus involved in sensory perception |
| GO:0000462 | 0.0064 | 217.7083 | 0.0064 | 1 | 25 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0048255 | 0.0081 | 168.4731 | 0.0082 | 1 | 32 | mRNA stabilization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 0 | 784.05 | 0.008 | 3 | 18 | protein targeting to Golgi |
| GO:0006891 | 0 | 293.55 | 0.0192 | 3 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0050911 | 0 | 55.847 | 0.1649 | 4 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 45.4855 | 0.201 | 4 | 451 | detection of chemical stimulus |
| GO:0007606 | 0 | 44.1623 | 0.2068 | 4 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0 | 44.1623 | 0.2068 | 4 | 464 | detection of stimulus involved in sensory perception |
| GO:0007186 | 9e-04 | 16.7705 | 0.5171 | 4 | 1160 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0.001 | 15.9625 | 0.5412 | 4 | 1214 | neurological system process |
| GO:0072594 | 0.002 | 17.8472 | 0.2835 | 3 | 636 | establishment of protein localization to organelle |
| GO:0006886 | 0.0068 | 11.4112 | 0.4328 | 3 | 971 | intracellular protein transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007369 | 1e-04 | Inf | 0.0228 | 2 | 179 | gastrulation |
| GO:0038092 | 0.0019 | 1120.5 | 0.0019 | 1 | 15 | nodal signaling pathway |
| GO:0009790 | 0.0039 | Inf | 0.1252 | 2 | 983 | embryo development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042502 | 6e-04 | Inf | 6e-04 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
| GO:0043456 | 0.0029 | 490.3125 | 0.0029 | 1 | 5 | regulation of pentose-phosphate shunt |
| GO:0016051 | 0.0052 | 23.0685 | 0.1112 | 2 | 194 | carbohydrate biosynthetic process |
| GO:0006006 | 0.0064 | 20.6676 | 0.1238 | 2 | 216 | glucose metabolic process |
| GO:0046689 | 0.0086 | 140 | 0.0086 | 1 | 15 | response to mercury ion |
| GO:0021542 | 0.0091 | 130.6583 | 0.0092 | 1 | 16 | dentate gyrus development |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048866 | 9e-04 | 2615.8333 | 9e-04 | 1 | 2 | stem cell fate specification |
| GO:0060214 | 0.0018 | 871.8333 | 0.0018 | 1 | 4 | endocardium formation |
| GO:0060836 | 0.0027 | 523.0333 | 0.0027 | 1 | 6 | lymphatic endothelial cell differentiation |
| GO:0060956 | 0.0027 | 523.0333 | 0.0027 | 1 | 6 | endocardial cell differentiation |
| GO:0090336 | 0.0031 | 435.8333 | 0.0031 | 1 | 7 | positive regulation of brown fat cell differentiation |
| GO:0043588 | 0.0049 | 25.2261 | 0.1101 | 2 | 247 | skin development |
| GO:0042789 | 0.0058 | 217.8333 | 0.0058 | 1 | 13 | mRNA transcription from RNA polymerase II promoter |
| GO:0001946 | 0.0062 | 201.0641 | 0.0062 | 1 | 14 | lymphangiogenesis |
| GO:0008544 | 0.0074 | 20.3208 | 0.136 | 2 | 305 | epidermis development |
| GO:0003159 | 0.0084 | 145.1667 | 0.0085 | 1 | 19 | morphogenesis of an endothelium |
| GO:0014850 | 0.0089 | 137.5175 | 0.0089 | 1 | 20 | response to muscle activity |
| GO:0030154 | 0.0092 | 8.2802 | 1.6248 | 5 | 3645 | cell differentiation |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050726 | 5e-04 | Inf | 5e-04 | 1 | 1 | positive regulation of interleukin-1 alpha biosynthetic process |
| GO:0045360 | 0.001 | 2242 | 0.001 | 1 | 2 | regulation of interleukin-1 biosynthetic process |
| GO:0043137 | 0.002 | 747.2381 | 0.002 | 1 | 4 | DNA replication, removal of RNA primer |
| GO:0071222 | 0.0025 | 34.5444 | 0.0774 | 2 | 152 | cellular response to lipopolysaccharide |
| GO:0071216 | 0.0034 | 29.5619 | 0.0902 | 2 | 177 | cellular response to biotic stimulus |
| GO:0019236 | 0.0036 | 373.5476 | 0.0036 | 1 | 7 | response to pheromone |
| GO:0032650 | 0.0036 | 373.5476 | 0.0036 | 1 | 7 | regulation of interleukin-1 alpha production |
| GO:0006273 | 0.0041 | 320.1633 | 0.0041 | 1 | 8 | lagging strand elongation |
| GO:0071223 | 0.0046 | 280.125 | 0.0046 | 1 | 9 | cellular response to lipoteichoic acid |
| GO:0010510 | 0.0051 | 248.9841 | 0.0051 | 1 | 10 | regulation of acetyl-CoA biosynthetic process from pyruvate |
| GO:0010172 | 0.0066 | 186.7024 | 0.0066 | 1 | 13 | embryonic body morphogenesis |
| GO:0051770 | 0.0066 | 186.7024 | 0.0066 | 1 | 13 | positive regulation of nitric-oxide synthase biosynthetic process |
| GO:0006085 | 0.0081 | 149.3333 | 0.0082 | 1 | 16 | acetyl-CoA biosynthetic process |
| GO:2000251 | 0.0081 | 149.3333 | 0.0082 | 1 | 16 | positive regulation of actin cytoskeleton reorganization |
| GO:0051707 | 0.0084 | 9.9454 | 0.4565 | 3 | 896 | response to other organism |
| GO:2000811 | 0.0086 | 139.9911 | 0.0087 | 1 | 17 | negative regulation of anoikis |
| GO:0033993 | 0.0088 | 9.737 | 0.4656 | 3 | 914 | response to lipid |
| GO:0042762 | 0.0091 | 131.7479 | 0.0092 | 1 | 18 | regulation of sulfur metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042742 | 0.003 | 34.2279 | 0.0871 | 2 | 228 | defense response to bacterium |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0.0016 | 83.3261 | 0.0707 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0.0024 | 67.9332 | 0.0862 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 0.0026 | 65.9654 | 0.0886 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0.0026 | 65.9654 | 0.0886 | 2 | 464 | detection of stimulus involved in sensory perception |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007369 | 1e-04 | Inf | 0.0228 | 2 | 179 | gastrulation |
| GO:0038092 | 0.0019 | 1120.5 | 0.0019 | 1 | 15 | nodal signaling pathway |
| GO:0009790 | 0.0039 | Inf | 0.1252 | 2 | 983 | embryo development |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006535 | 9e-04 | 2615.8333 | 9e-04 | 1 | 2 | cysteine biosynthetic process from serine |
| GO:0043418 | 9e-04 | 2615.8333 | 9e-04 | 1 | 2 | homocysteine catabolic process |
| GO:0006565 | 0.0013 | 1307.8333 | 0.0013 | 1 | 3 | L-serine catabolic process |
| GO:0019343 | 0.0013 | 1307.8333 | 0.0013 | 1 | 3 | cysteine biosynthetic process via cystathionine |
| GO:0019448 | 0.0013 | 1307.8333 | 0.0013 | 1 | 3 | L-cysteine catabolic process |
| GO:0042262 | 0.0013 | 1307.8333 | 0.0013 | 1 | 3 | DNA protection |
| GO:0019346 | 0.0018 | 871.8333 | 0.0018 | 1 | 4 | transsulfuration |
| GO:0070814 | 0.0018 | 871.8333 | 0.0018 | 1 | 4 | hydrogen sulfide biosynthetic process |
| GO:0045091 | 0.0036 | 373.5476 | 0.0036 | 1 | 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0039694 | 0.0062 | 201.0641 | 0.0062 | 1 | 14 | viral RNA genome replication |
| GO:0050930 | 0.0062 | 201.0641 | 0.0062 | 1 | 14 | induction of positive chemotaxis |
| GO:0009070 | 0.0071 | 174.2333 | 0.0071 | 1 | 16 | serine family amino acid biosynthetic process |
| GO:0006346 | 0.008 | 153.7157 | 0.008 | 1 | 18 | methylation-dependent chromatin silencing |
| GO:0000097 | 0.0084 | 145.1667 | 0.0085 | 1 | 19 | sulfur amino acid biosynthetic process |
| GO:0036499 | 0.0084 | 145.1667 | 0.0085 | 1 | 19 | PERK-mediated unfolded protein response |
| GO:0033141 | 0.0093 | 130.6333 | 0.0094 | 1 | 21 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035589 | 0.0025 | 581.1111 | 0.0025 | 1 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:0009813 | 0.0046 | 307.4902 | 0.0046 | 1 | 18 | flavonoid biosynthetic process |
| GO:0052696 | 0.0051 | 275.0877 | 0.0051 | 1 | 20 | flavonoid glucuronidation |
| GO:0007194 | 0.0061 | 227.1884 | 0.0061 | 1 | 24 | negative regulation of adenylate cyclase activity |
| GO:0035587 | 0.0069 | 200.9359 | 0.0069 | 1 | 27 | purinergic receptor signaling pathway |
| GO:0019585 | 0.0076 | 180.1149 | 0.0076 | 1 | 30 | glucuronate metabolic process |
| GO:0030803 | 0.0096 | 141.0991 | 0.0097 | 1 | 38 | negative regulation of cyclic nucleotide biosynthetic process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 0 | 1045.4667 | 0.0069 | 3 | 18 | protein targeting to Golgi |
| GO:0006891 | 0 | 391.425 | 0.0164 | 3 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0050911 | 2e-04 | 41.7711 | 0.1414 | 3 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 4e-04 | 34.0379 | 0.1723 | 3 | 451 | detection of chemical stimulus |
| GO:0007606 | 5e-04 | 33.0499 | 0.1773 | 3 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 5e-04 | 33.0499 | 0.1773 | 3 | 464 | detection of stimulus involved in sensory perception |
| GO:0072594 | 0.0012 | 23.7978 | 0.243 | 3 | 636 | establishment of protein localization to organelle |
| GO:0006886 | 0.0041 | 15.2159 | 0.371 | 3 | 971 | intracellular protein transport |
| GO:0007186 | 0.0068 | 12.567 | 0.4432 | 3 | 1160 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0.0077 | 11.962 | 0.4639 | 3 | 1214 | neurological system process |
| GO:0016192 | 0.0094 | 11.0839 | 0.4975 | 3 | 1302 | vesicle-mediated transport |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071918 | 0.0011 | 1569.5 | 0.0011 | 1 | 6 | urea transmembrane transport |
| GO:0050911 | 0.0016 | 83.3261 | 0.0707 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019755 | 0.0019 | 871.7222 | 0.0019 | 1 | 10 | one-carbon compound transport |
| GO:0015793 | 0.0021 | 784.5 | 0.0021 | 1 | 11 | glycerol transport |
| GO:0009593 | 0.0024 | 67.9332 | 0.0862 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 0.0026 | 65.9654 | 0.0886 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0.0026 | 65.9654 | 0.0886 | 2 | 464 | detection of stimulus involved in sensory perception |
| GO:0006833 | 0.0074 | 206.0789 | 0.0075 | 1 | 39 | water transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006972 | 0.0027 | 784.05 | 0.0027 | 1 | 21 | hyperosmotic response |
| GO:0042104 | 0.0034 | 602.8846 | 0.0034 | 1 | 27 | positive regulation of activated T cell proliferation |
| GO:0031295 | 0.0093 | 217.0694 | 0.0093 | 1 | 73 | T cell costimulation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 6e-04 | Inf | 0.0471 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 8e-04 | Inf | 0.0574 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 9e-04 | Inf | 0.0591 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 9e-04 | Inf | 0.0591 | 2 | 464 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0.0055 | Inf | 0.1477 | 2 | 1160 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0.006 | Inf | 0.1546 | 2 | 1214 | neurological system process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 0 | Inf | 0.0057 | 5 | 18 | protein targeting to Golgi |
| GO:0006891 | 0 | Inf | 0.0137 | 5 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0072594 | 0 | Inf | 0.2025 | 5 | 636 | establishment of protein localization to organelle |
| GO:0006886 | 0 | Inf | 0.3092 | 5 | 971 | intracellular protein transport |
| GO:0016192 | 0 | Inf | 0.4146 | 5 | 1302 | vesicle-mediated transport |
| GO:0070727 | 0 | Inf | 0.4684 | 5 | 1471 | cellular macromolecule localization |
| GO:1902582 | 0 | Inf | 0.5235 | 5 | 1644 | single-organism intracellular transport |
| GO:0008104 | 1e-04 | Inf | 0.7381 | 5 | 2318 | protein localization |
| GO:0071702 | 1e-04 | Inf | 0.7948 | 5 | 2496 | organic substance transport |
| GO:0051649 | 1e-04 | Inf | 0.7951 | 5 | 2497 | establishment of localization in cell |
| GO:1902578 | 9e-04 | Inf | 1.2431 | 5 | 3904 | single-organism localization |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061088 | 0.0013 | 1743.5556 | 0.0013 | 1 | 10 | regulation of sequestering of zinc ion |
| GO:0006882 | 0.0027 | 784.05 | 0.0027 | 1 | 21 | cellular zinc ion homeostasis |
| GO:0071577 | 0.0028 | 746.6667 | 0.0028 | 1 | 22 | zinc II ion transmembrane transport |
| GO:0010043 | 0.0067 | 300.9423 | 0.0068 | 1 | 53 | response to zinc ion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010868 | 3e-04 | 15700 | 3e-04 | 1 | 2 | negative regulation of triglyceride biosynthetic process |
| GO:0032792 | 6e-04 | 3924.25 | 6e-04 | 1 | 5 | negative regulation of CREB transcription factor activity |
| GO:2000210 | 9e-04 | 2615.8333 | 9e-04 | 1 | 7 | positive regulation of anoikis |
| GO:0045721 | 0.0015 | 1426.3636 | 0.0015 | 1 | 12 | negative regulation of gluconeogenesis |
| GO:0043153 | 0.0024 | 871.2778 | 0.0024 | 1 | 19 | entrainment of circadian clock by photoperiod |
| GO:0090207 | 0.0043 | 474.7879 | 0.0043 | 1 | 34 | regulation of triglyceride metabolic process |
| GO:0010830 | 0.0069 | 295.2453 | 0.0069 | 1 | 54 | regulation of myotube differentiation |
| GO:0045912 | 0.007 | 289.7593 | 0.007 | 1 | 55 | negative regulation of carbohydrate metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007586 | 0 | 293.2075 | 0.0413 | 3 | 162 | digestion |
| GO:0005975 | 9e-04 | 46.1105 | 0.245 | 3 | 962 | carbohydrate metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045091 | 0.0025 | 560.3929 | 0.0025 | 1 | 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0007186 | 0.0036 | 18.8518 | 0.3694 | 3 | 1160 | G-protein coupled receptor signaling pathway |
| GO:0039694 | 0.0045 | 301.6346 | 0.0045 | 1 | 14 | viral RNA genome replication |
| GO:0050930 | 0.0045 | 301.6346 | 0.0045 | 1 | 14 | induction of positive chemotaxis |
| GO:0050911 | 0.0053 | 27.7717 | 0.1178 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0036499 | 0.006 | 217.7778 | 0.006 | 1 | 19 | PERK-mediated unfolded protein response |
| GO:0009593 | 0.0078 | 22.6414 | 0.1436 | 2 | 451 | detection of chemical stimulus |
| GO:0042119 | 0.0079 | 163.2708 | 0.008 | 1 | 25 | neutrophil activation |
| GO:0050926 | 0.0079 | 163.2708 | 0.008 | 1 | 25 | regulation of positive chemotaxis |
| GO:0090023 | 0.0079 | 163.2708 | 0.008 | 1 | 25 | positive regulation of neutrophil chemotaxis |
| GO:0007606 | 0.0082 | 21.9856 | 0.1477 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0.0082 | 21.9856 | 0.1477 | 2 | 464 | detection of stimulus involved in sensory perception |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007586 | 0 | 146.5943 | 0.0516 | 3 | 162 | digestion |
| GO:0032776 | 0 | 316.4646 | 0.0111 | 2 | 35 | DNA methylation on cytosine |
| GO:0000183 | 1e-04 | 267.6752 | 0.0131 | 2 | 41 | chromatin silencing at rDNA |
| GO:0045815 | 2e-04 | 138.8711 | 0.0245 | 2 | 77 | positive regulation of gene expression, epigenetic |
| GO:0006305 | 3e-04 | 122.4549 | 0.0277 | 2 | 87 | DNA alkylation |
| GO:0044728 | 4e-04 | 106.1224 | 0.0318 | 2 | 100 | DNA methylation or demethylation |
| GO:0006334 | 6e-04 | 87.2773 | 0.0385 | 2 | 121 | nucleosome assembly |
| GO:0031047 | 9e-04 | 70.5261 | 0.0474 | 2 | 149 | gene silencing by RNA |
| GO:0045814 | 9e-04 | 69.5705 | 0.0481 | 2 | 151 | negative regulation of gene expression, epigenetic |
| GO:0006333 | 0.001 | 64.3354 | 0.0519 | 2 | 163 | chromatin assembly or disassembly |
| GO:0006323 | 0.0012 | 60.5341 | 0.0551 | 2 | 173 | DNA packaging |
| GO:0071824 | 0.0015 | 53.5579 | 0.0621 | 2 | 195 | protein-DNA complex subunit organization |
| GO:0005975 | 0.0021 | 23.0537 | 0.3063 | 3 | 962 | carbohydrate metabolic process |
| GO:0043414 | 0.0028 | 38.8252 | 0.085 | 2 | 267 | macromolecule methylation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002642 | 4e-04 | Inf | 4e-04 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0002377 | 4e-04 | 97.6063 | 0.0313 | 2 | 82 | immunoglobulin production |
| GO:2001274 | 0.0011 | 1569.5 | 0.0011 | 1 | 3 | negative regulation of glucose import in response to insulin stimulus |
| GO:0070317 | 0.0015 | 1046.2667 | 0.0015 | 1 | 4 | negative regulation of G0 to G1 transition |
| GO:0010890 | 0.0027 | 523.0333 | 0.0027 | 1 | 7 | positive regulation of sequestering of triglyceride |
| GO:0034389 | 0.0053 | 241.2923 | 0.0053 | 1 | 14 | lipid particle organization |
| GO:0033622 | 0.0061 | 209.0933 | 0.0061 | 1 | 16 | integrin activation |
| GO:0010829 | 0.0069 | 184.4706 | 0.0069 | 1 | 18 | negative regulation of glucose transport |
| GO:0016338 | 0.0088 | 142.5 | 0.0088 | 1 | 23 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061088 | 0.0013 | 1743.5556 | 0.0013 | 1 | 10 | regulation of sequestering of zinc ion |
| GO:0000028 | 0.002 | 1045.7333 | 0.002 | 1 | 16 | ribosomal small subunit assembly |
| GO:0006882 | 0.0027 | 784.05 | 0.0027 | 1 | 21 | cellular zinc ion homeostasis |
| GO:0071577 | 0.0028 | 746.6667 | 0.0028 | 1 | 22 | zinc II ion transmembrane transport |
| GO:0000462 | 0.0032 | 653.2083 | 0.0032 | 1 | 25 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
| GO:0010043 | 0.0067 | 300.9423 | 0.0068 | 1 | 53 | response to zinc ion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061088 | 0.0019 | 871.7222 | 0.0019 | 1 | 10 | regulation of sequestering of zinc ion |
| GO:0006882 | 0.004 | 392 | 0.004 | 1 | 21 | cellular zinc ion homeostasis |
| GO:0071577 | 0.0042 | 373.3095 | 0.0042 | 1 | 22 | zinc II ion transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061088 | 0.0025 | 581.1111 | 0.0025 | 1 | 10 | regulation of sequestering of zinc ion |
| GO:0050911 | 0.0032 | 41.6603 | 0.0942 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0.0048 | 33.9644 | 0.1149 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 0.005 | 32.9805 | 0.1182 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 0.005 | 32.9805 | 0.1182 | 2 | 464 | detection of stimulus involved in sensory perception |
| GO:0006882 | 0.0053 | 261.3167 | 0.0053 | 1 | 21 | cellular zinc ion homeostasis |
| GO:0071577 | 0.0056 | 248.8571 | 0.0056 | 1 | 22 | zinc II ion transmembrane transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 6e-04 | Inf | 0.0471 | 2 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 8e-04 | Inf | 0.0574 | 2 | 451 | detection of chemical stimulus |
| GO:0007606 | 9e-04 | Inf | 0.0591 | 2 | 464 | sensory perception of chemical stimulus |
| GO:0050906 | 9e-04 | Inf | 0.0591 | 2 | 464 | detection of stimulus involved in sensory perception |
| GO:0007186 | 0.0055 | Inf | 0.1477 | 2 | 1160 | G-protein coupled receptor signaling pathway |
| GO:0050877 | 0.006 | Inf | 0.1546 | 2 | 1214 | neurological system process |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001881 | 0.0017 | Inf | 0.0017 | 1 | 27 | receptor recycling |
| GO:0033572 | 0.0022 | Inf | 0.0022 | 1 | 35 | transferrin transport |
| GO:0072512 | 0.0024 | Inf | 0.0024 | 1 | 37 | trivalent inorganic cation transport |
| GO:0006826 | 0.0034 | Inf | 0.0034 | 1 | 53 | iron ion transport |
| GO:0098792 | 0.0068 | Inf | 0.0068 | 1 | 106 | xenophagy |
| GO:0002230 | 0.0078 | Inf | 0.0078 | 1 | 122 | positive regulation of defense response to virus by host |
| GO:0098779 | 0.0084 | Inf | 0.0084 | 1 | 132 | mitophagy in response to mitochondrial depolarization |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 2e-04 | 41.8937 | 0.141 | 3 | 370 | olfactory receptor activity |
| GO:0004930 | 0.0022 | 19.2339 | 0.2976 | 3 | 781 | G-protein coupled receptor activity |
| GO:0016175 | 0.003 | 449.5714 | 0.003 | 1 | 8 | superoxide-generating NADPH oxidase activity |
| GO:0099600 | 0.0077 | 11.9777 | 0.4633 | 3 | 1216 | transmembrane receptor activity |
| GO:0038023 | 0.0087 | 11.4344 | 0.4835 | 3 | 1269 | signaling receptor activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005160 | 0.0062 | 327.0417 | 0.0062 | 1 | 49 | transforming growth factor beta receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008140 | 0.0019 | 874.2222 | 0.0019 | 1 | 10 | cAMP response element binding protein binding |
| GO:0071889 | 0.0038 | 413.8421 | 0.0038 | 1 | 20 | 14-3-3 protein binding |
| GO:0005385 | 0.004 | 393.125 | 0.004 | 1 | 21 | zinc ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035575 | 0 | 483.9385 | 0.0067 | 2 | 15 | histone demethylase activity (H4-K20 specific) |
| GO:0032451 | 1e-04 | 179.4971 | 0.0164 | 2 | 37 | demethylase activity |
| GO:0008009 | 2e-04 | 136.4783 | 0.0213 | 2 | 48 | chemokine activity |
| GO:0042393 | 0.0022 | 37.9927 | 0.0738 | 2 | 166 | histone binding |
| GO:0031726 | 0.0027 | 524.5333 | 0.0027 | 1 | 6 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0027 | 524.5333 | 0.0027 | 1 | 6 | CCR5 chemokine receptor binding |
| GO:0008140 | 0.0044 | 291.3333 | 0.0044 | 1 | 10 | cAMP response element binding protein binding |
| GO:0001664 | 0.005 | 24.9887 | 0.1111 | 2 | 250 | G-protein coupled receptor binding |
| GO:0005126 | 0.0056 | 23.45 | 0.1182 | 2 | 266 | cytokine receptor binding |
| GO:0071889 | 0.0089 | 137.9123 | 0.0089 | 1 | 20 | 14-3-3 protein binding |
| GO:0048020 | 0.0099 | 125.664 | 0.0099 | 1 | 26 | CCR chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001965 | 0.0053 | 262.0667 | 0.0053 | 1 | 21 | G-protein alpha-subunit binding |
| GO:0042605 | 0.0061 | 227.8406 | 0.0061 | 1 | 24 | peptide antigen binding |
| GO:0030515 | 0.0063 | 218.3333 | 0.0064 | 1 | 25 | snoRNA binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030515 | 0.0032 | 655.0833 | 0.0032 | 1 | 25 | snoRNA binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008536 | 0.0073 | 187.0952 | 0.0074 | 1 | 29 | Ran GTPase binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008140 | 0.0025 | 582.7778 | 0.0025 | 1 | 10 | cAMP response element binding protein binding |
| GO:0071889 | 0.0051 | 275.8772 | 0.0051 | 1 | 20 | 14-3-3 protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0032 | 41.7826 | 0.094 | 2 | 370 | olfactory receptor activity |
| GO:0030515 | 0.0063 | 218.3333 | 0.0064 | 1 | 25 | snoRNA binding |
| GO:0045182 | 0.0086 | 158.697 | 0.0086 | 1 | 34 | translation regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | Inf | 0.094 | 4 | 370 | olfactory receptor activity |
| GO:0004930 | 0 | Inf | 0.1984 | 4 | 781 | G-protein coupled receptor activity |
| GO:0099600 | 0 | Inf | 0.3089 | 4 | 1216 | transmembrane receptor activity |
| GO:0038023 | 0 | Inf | 0.3223 | 4 | 1269 | signaling receptor activity |
| GO:0060089 | 1e-04 | Inf | 0.3823 | 4 | 1505 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038100 | 4e-04 | 7872 | 4e-04 | 1 | 2 | nodal binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004082 | 0.0025 | 582.7778 | 0.0025 | 1 | 4 | bisphosphoglycerate mutase activity |
| GO:0046538 | 0.0025 | 582.7778 | 0.0025 | 1 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0004083 | 0.0032 | 437.0556 | 0.0032 | 1 | 5 | bisphosphoglycerate 2-phosphatase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071862 | 6e-04 | 3935.5 | 6e-04 | 1 | 2 | protein phosphatase type 1 activator activity |
| GO:0008508 | 0.0016 | 983.6875 | 0.0016 | 1 | 5 | bile acid:sodium symporter activity |
| GO:0019957 | 0.0022 | 655.7083 | 0.0022 | 1 | 7 | C-C chemokine binding |
| GO:0019211 | 0.0035 | 393.325 | 0.0035 | 1 | 11 | phosphatase activator activity |
| GO:0008157 | 0.0063 | 206.8947 | 0.0064 | 1 | 20 | protein phosphatase 1 binding |
| GO:0050699 | 0.007 | 187.1667 | 0.007 | 1 | 22 | WW domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0078 | 20.8886 | 0.141 | 2 | 370 | olfactory receptor activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004740 | 0.0021 | 786.75 | 0.0021 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
| GO:0016503 | 0.0021 | 786.75 | 0.0021 | 1 | 3 | pheromone receptor activity |
| GO:0055131 | 0.0042 | 314.64 | 0.0042 | 1 | 6 | C3HC4-type RING finger domain binding |
| GO:0044183 | 0.0097 | 120.9538 | 0.0098 | 1 | 14 | protein binding involved in protein folding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001055 | 0.0013 | 1748.5556 | 0.0013 | 1 | 10 | RNA polymerase II activity |
| GO:0001054 | 0.0015 | 1430.4545 | 0.0015 | 1 | 12 | RNA polymerase I activity |
| GO:0005132 | 0.0022 | 983.125 | 0.0022 | 1 | 17 | type I interferon receptor binding |
| GO:0001056 | 0.0023 | 925.2353 | 0.0023 | 1 | 18 | RNA polymerase III activity |
| GO:0034062 | 0.0053 | 383.0488 | 0.0053 | 1 | 42 | RNA polymerase activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005130 | 5e-04 | Inf | 5e-04 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0004740 | 0.0015 | 1124.1429 | 0.0015 | 1 | 3 | pyruvate dehydrogenase (acetyl-transferring) kinase activity |
| GO:0016503 | 0.0015 | 1124.1429 | 0.0015 | 1 | 3 | pheromone receptor activity |
| GO:0004523 | 0.0036 | 374.619 | 0.0036 | 1 | 7 | RNA-DNA hybrid ribonuclease activity |
| GO:0005125 | 0.0049 | 24.2989 | 0.1092 | 2 | 215 | cytokine activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071862 | 8e-04 | 3148.2 | 8e-04 | 1 | 2 | protein phosphatase type 1 activator activity |
| GO:0019211 | 0.0042 | 314.64 | 0.0042 | 1 | 11 | phosphatase activator activity |
| GO:0005132 | 0.0065 | 196.575 | 0.0065 | 1 | 17 | type I interferon receptor binding |
| GO:0008157 | 0.0076 | 165.5053 | 0.0076 | 1 | 20 | protein phosphatase 1 binding |
| GO:0004984 | 0.0078 | 20.8886 | 0.141 | 2 | 370 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0032 | 41.7826 | 0.094 | 2 | 370 | olfactory receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0038100 | 1e-04 | Inf | 1e-04 | 1 | 2 | nodal binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004124 | 5e-04 | Inf | 5e-04 | 1 | 1 | cysteine synthase activity |
| GO:0050421 | 5e-04 | Inf | 5e-04 | 1 | 1 | nitrite reductase (NO-forming) activity |
| GO:0070025 | 5e-04 | Inf | 5e-04 | 1 | 1 | carbon monoxide binding |
| GO:1904047 | 5e-04 | Inf | 5e-04 | 1 | 1 | S-adenosyl-L-methionine binding |
| GO:0004122 | 0.001 | 2248.4286 | 0.001 | 1 | 2 | cystathionine beta-synthase activity |
| GO:0005153 | 0.001 | 2248.4286 | 0.001 | 1 | 2 | interleukin-8 receptor binding |
| GO:0070026 | 0.001 | 2248.4286 | 0.001 | 1 | 2 | nitric oxide binding |
| GO:0016661 | 0.0015 | 1124.1429 | 0.0015 | 1 | 3 | oxidoreductase activity, acting on other nitrogenous compounds as donors |
| GO:0005125 | 0.0049 | 24.2989 | 0.1092 | 2 | 215 | cytokine activity |
| GO:0005132 | 0.0086 | 140.3929 | 0.0086 | 1 | 17 | type I interferon receptor binding |
| GO:0008327 | 0.0096 | 124.7778 | 0.0097 | 1 | 19 | methyl-CpG binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045028 | 0.0019 | 874.2222 | 0.0019 | 1 | 10 | G-protein coupled purinergic nucleotide receptor activity |
| GO:0016502 | 0.0032 | 491.5312 | 0.0032 | 1 | 17 | nucleotide receptor activity |
| GO:0035586 | 0.004 | 393.125 | 0.004 | 1 | 21 | purinergic receptor activity |
| GO:0015020 | 0.0063 | 245.5156 | 0.0063 | 1 | 33 | glucuronosyltransferase activity |
| GO:0004930 | 0.0071 | 38.4236 | 0.1488 | 2 | 781 | G-protein coupled receptor activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004523 | 0.0018 | 874.3333 | 0.0018 | 1 | 7 | RNA-DNA hybrid ribonuclease activity |
| GO:0005149 | 0.0038 | 374.5238 | 0.0038 | 1 | 15 | interleukin-1 receptor binding |
| GO:0050699 | 0.0056 | 249.5714 | 0.0056 | 1 | 22 | WW domain binding |
| GO:0016893 | 0.0094 | 145.4444 | 0.0094 | 1 | 37 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | Inf | 0.0705 | 3 | 370 | olfactory receptor activity |
| GO:0004930 | 1e-04 | Inf | 0.1488 | 3 | 781 | G-protein coupled receptor activity |
| GO:0099600 | 5e-04 | Inf | 0.2316 | 3 | 1216 | transmembrane receptor activity |
| GO:0038023 | 5e-04 | Inf | 0.2417 | 3 | 1269 | signaling receptor activity |
| GO:0060089 | 9e-04 | Inf | 0.2867 | 3 | 1505 | molecular transducer activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015204 | 0.0015 | 1049.2667 | 0.0015 | 1 | 6 | urea transmembrane transporter activity |
| GO:0015250 | 0.0028 | 524.4667 | 0.0028 | 1 | 11 | water channel activity |
| GO:0015254 | 0.0028 | 524.4667 | 0.0028 | 1 | 11 | glycerol channel activity |
| GO:0015166 | 0.003 | 476.7576 | 0.003 | 1 | 12 | polyol transmembrane transporter activity |
| GO:0004984 | 0.0032 | 41.7826 | 0.094 | 2 | 370 | olfactory receptor activity |
| GO:0015144 | 0.0089 | 154.0196 | 0.0089 | 1 | 35 | carbohydrate transmembrane transporter activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 4e-04 | 31.4183 | 0.1645 | 3 | 370 | olfactory receptor activity |
| GO:0004930 | 0.0037 | 14.4245 | 0.3472 | 3 | 781 | G-protein coupled receptor activity |
| GO:0001055 | 0.0044 | 291.3333 | 0.0044 | 1 | 10 | RNA polymerase II activity |
| GO:0001054 | 0.0053 | 238.3333 | 0.0053 | 1 | 12 | RNA polymerase I activity |
| GO:0001056 | 0.008 | 154.1569 | 0.008 | 1 | 18 | RNA polymerase III activity |
| GO:0008270 | 0.0097 | 9.9825 | 0.4903 | 3 | 1103 | zinc ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 6e-04 | Inf | 0.047 | 2 | 370 | olfactory receptor activity |
| GO:0004930 | 0.0025 | Inf | 0.0992 | 2 | 781 | G-protein coupled receptor activity |
| GO:0099600 | 0.006 | Inf | 0.1544 | 2 | 1216 | transmembrane receptor activity |
| GO:0038023 | 0.0065 | Inf | 0.1612 | 2 | 1269 | signaling receptor activity |
| GO:0060089 | 0.0091 | Inf | 0.1911 | 2 | 1505 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008140 | 0.0019 | 874.2222 | 0.0019 | 1 | 10 | cAMP response element binding protein binding |
| GO:0071889 | 0.0038 | 413.8421 | 0.0038 | 1 | 20 | 14-3-3 protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008536 | 0.0018 | Inf | 0.0018 | 1 | 29 | Ran GTPase binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005385 | 0.0053 | 262.0667 | 0.0053 | 1 | 21 | zinc ion transmembrane transporter activity |
| GO:0005031 | 0.0058 | 238.2121 | 0.0058 | 1 | 23 | tumor necrosis factor-activated receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008140 | 0.0013 | 1748.5556 | 0.0013 | 1 | 10 | cAMP response element binding protein binding |
| GO:0071889 | 0.0025 | 827.7368 | 0.0025 | 1 | 20 | 14-3-3 protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | 23613 | 0.0013 | 3 | 5 | alpha-amylase activity |
| GO:0004553 | 0 | 539.8966 | 0.0229 | 3 | 90 | hydrolase activity, hydrolyzing O-glycosyl compounds |
| GO:0016787 | 4e-04 | Inf | 0.5779 | 4 | 2275 | hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005153 | 6e-04 | 3935.5 | 6e-04 | 1 | 2 | interleukin-8 receptor binding |
| GO:0099600 | 0.0041 | 17.9678 | 0.3861 | 3 | 1216 | transmembrane receptor activity |
| GO:0038023 | 0.0046 | 17.1528 | 0.4029 | 3 | 1269 | signaling receptor activity |
| GO:0004984 | 0.0053 | 27.8533 | 0.1175 | 2 | 370 | olfactory receptor activity |
| GO:0060089 | 0.0075 | 14.222 | 0.4778 | 3 | 1505 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004556 | 0 | 11805.75 | 0.0016 | 3 | 5 | alpha-amylase activity |
| GO:0004553 | 0 | 269.931 | 0.0286 | 3 | 90 | hydrolase activity, hydrolyzing O-glycosyl compounds |
| GO:0042393 | 0.0011 | 63.3293 | 0.0527 | 2 | 166 | histone binding |
| GO:0046982 | 0.0077 | 22.8128 | 0.1426 | 2 | 449 | protein heterodimerization activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005125 | 0.0018 | 48.6072 | 0.0683 | 2 | 215 | cytokine activity |
| GO:0005132 | 0.0054 | 245.7344 | 0.0054 | 1 | 17 | type I interferon receptor binding |
| GO:0005385 | 0.0067 | 196.5375 | 0.0067 | 1 | 21 | zinc ion transmembrane transporter activity |
| GO:0005164 | 0.0089 | 145.5185 | 0.0089 | 1 | 28 | tumor necrosis factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005385 | 0.0027 | 786.3 | 0.0027 | 1 | 21 | zinc ion transmembrane transporter activity |
| GO:0030515 | 0.0032 | 655.0833 | 0.0032 | 1 | 25 | snoRNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005385 | 0.0027 | 786.3 | 0.0027 | 1 | 21 | zinc ion transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0.0016 | 83.5707 | 0.0705 | 2 | 370 | olfactory receptor activity |
| GO:0005385 | 0.004 | 393.125 | 0.004 | 1 | 21 | zinc ion transmembrane transporter activity |
| GO:0004930 | 0.0071 | 38.4236 | 0.1488 | 2 | 781 | G-protein coupled receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042813 | 0.0063 | 206.8947 | 0.0064 | 1 | 20 | Wnt-activated receptor activity |
| GO:0005385 | 0.0067 | 196.5375 | 0.0067 | 1 | 21 | zinc ion transmembrane transporter activity |
| GO:0017147 | 0.0095 | 135.4655 | 0.0095 | 1 | 30 | Wnt-protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 6e-04 | Inf | 0.047 | 2 | 370 | olfactory receptor activity |
| GO:0004930 | 0.0025 | Inf | 0.0992 | 2 | 781 | G-protein coupled receptor activity |
| GO:0099600 | 0.006 | Inf | 0.1544 | 2 | 1216 | transmembrane receptor activity |
| GO:0038023 | 0.0065 | Inf | 0.1612 | 2 | 1269 | signaling receptor activity |
| GO:0060089 | 0.0091 | Inf | 0.1911 | 2 | 1505 | molecular transducer activity |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001664 | 4e-04 | 26.8785 | 0.1588 | 3 | 250 | G-protein coupled receptor binding |
| GO:0099600 | 5e-04 | 11.9959 | 0.7722 | 5 | 1216 | transmembrane receptor activity |
| GO:0038023 | 6e-04 | 11.4509 | 0.8058 | 5 | 1269 | signaling receptor activity |
| GO:0004930 | 0.001 | 12.8366 | 0.4959 | 4 | 781 | G-protein coupled receptor activity |
| GO:0031696 | 0.0013 | 1748.5556 | 0.0013 | 1 | 2 | alpha-2C adrenergic receptor binding |
| GO:0046811 | 0.0013 | 1748.5556 | 0.0013 | 1 | 2 | histone deacetylase inhibitor activity |
| GO:0060089 | 0.0013 | 9.492 | 0.9557 | 5 | 1505 | molecular transducer activity |
| GO:0004984 | 0.0014 | 17.9498 | 0.235 | 3 | 370 | olfactory receptor activity |
| GO:0004938 | 0.0019 | 874.2222 | 0.0019 | 1 | 3 | alpha2-adrenergic receptor activity |
| GO:0031692 | 0.0019 | 874.2222 | 0.0019 | 1 | 3 | alpha-1B adrenergic receptor binding |
| GO:0032795 | 0.0019 | 874.2222 | 0.0019 | 1 | 3 | heterotrimeric G-protein binding |
| GO:0051380 | 0.0025 | 582.7778 | 0.0025 | 1 | 4 | norepinephrine binding |
| GO:0051430 | 0.0025 | 582.7778 | 0.0025 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
| GO:0051431 | 0.0025 | 582.7778 | 0.0025 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
| GO:0051379 | 0.0038 | 349.6222 | 0.0038 | 1 | 6 | epinephrine binding |
| GO:0004935 | 0.0057 | 218.4722 | 0.0057 | 1 | 9 | adrenergic receptor activity |
| GO:0031996 | 0.0082 | 145.6111 | 0.0083 | 1 | 13 | thioesterase binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032078 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:0048211 | 0.002 | 1045.9333 | 0.002 | 1 | 2 | Golgi vesicle docking |
| GO:0060764 | 0.002 | 1045.9333 | 0.002 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0015820 | 0.0031 | 522.9333 | 0.0031 | 1 | 3 | leucine transport |
| GO:0032074 | 0.0031 | 522.9333 | 0.0031 | 1 | 3 | negative regulation of nuclease activity |
| GO:0060435 | 0.0031 | 522.9333 | 0.0031 | 1 | 3 | bronchiole development |
| GO:0070458 | 0.0031 | 522.9333 | 0.0031 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:0018916 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | nitrobenzene metabolic process |
| GO:0060480 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0070317 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | negative regulation of G0 to G1 transition |
| GO:1901387 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | positive regulation of voltage-gated calcium channel activity |
| GO:0060482 | 0.0061 | 209.1333 | 0.0061 | 1 | 6 | lobar bronchus development |
| GO:0035524 | 0.0071 | 174.2667 | 0.0071 | 1 | 7 | proline transmembrane transport |
| GO:0045647 | 0.0071 | 174.2667 | 0.0071 | 1 | 7 | negative regulation of erythrocyte differentiation |
| GO:2001300 | 0.0071 | 174.2667 | 0.0071 | 1 | 7 | lipoxin metabolic process |
| GO:0032070 | 0.0081 | 149.3619 | 0.0081 | 1 | 8 | regulation of deoxyribonuclease activity |
| GO:0060638 | 0.0091 | 130.6833 | 0.0092 | 1 | 9 | mesenchymal-epithelial cell signaling |
| GO:0043112 | 0.0093 | 15.5315 | 0.1477 | 2 | 145 | receptor metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006584 | 0.0019 | 34.7533 | 0.0658 | 2 | 47 | catecholamine metabolic process |
| GO:1902952 | 0.0028 | 746.8095 | 0.0028 | 1 | 2 | positive regulation of dendritic spine maintenance |
| GO:1902897 | 0.0042 | 373.381 | 0.0042 | 1 | 3 | regulation of postsynaptic density protein 95 clustering |
| GO:2000232 | 0.0042 | 373.381 | 0.0042 | 1 | 3 | regulation of rRNA processing |
| GO:0002408 | 0.0056 | 248.9048 | 0.0056 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0048680 | 0.007 | 186.6667 | 0.007 | 1 | 5 | positive regulation of axon regeneration |
| GO:0061737 | 0.007 | 186.6667 | 0.007 | 1 | 5 | leukotriene signaling pathway |
| GO:0018958 | 0.0073 | 17.3267 | 0.1289 | 2 | 92 | phenol-containing compound metabolic process |
| GO:1901838 | 0.0084 | 149.3238 | 0.0084 | 1 | 6 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
| GO:0008090 | 0.0098 | 124.4286 | 0.0098 | 1 | 7 | retrograde axonal transport |
| GO:0051694 | 0.0098 | 124.4286 | 0.0098 | 1 | 7 | pointed-end actin filament capping |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007147 | 0.0017 | 1307.6667 | 0.0017 | 1 | 2 | female meiosis II |
| GO:1902530 | 0.0017 | 1307.6667 | 0.0017 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:1903551 | 0.005 | 261.4667 | 0.005 | 1 | 6 | regulation of extracellular exosome assembly |
| GO:2000271 | 0.005 | 261.4667 | 0.005 | 1 | 6 | positive regulation of fibroblast apoptotic process |
| GO:0070424 | 0.0074 | 163.3854 | 0.0074 | 1 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0097341 | 0.0074 | 163.3854 | 0.0074 | 1 | 9 | zymogen inhibition |
| GO:1990001 | 0.0074 | 163.3854 | 0.0074 | 1 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0034553 | 0.002 | Inf | 0.002 | 1 | 1 | mitochondrial respiratory chain complex II assembly |
| GO:0045494 | 0.0028 | 28.3793 | 0.079 | 2 | 40 | photoreceptor cell maintenance |
| GO:0006682 | 0.0039 | 522.4667 | 0.0039 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0038060 | 0.0039 | 522.4667 | 0.0039 | 1 | 2 | nitric oxide-cGMP-mediated signaling pathway |
| GO:0021759 | 0.0059 | 261.2167 | 0.0059 | 1 | 3 | globus pallidus development |
| GO:0002408 | 0.0079 | 174.1333 | 0.0079 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0038108 | 0.0079 | 174.1333 | 0.0079 | 1 | 4 | negative regulation of appetite by leptin-mediated signaling pathway |
| GO:2000048 | 0.0079 | 174.1333 | 0.0079 | 1 | 4 | negative regulation of cell-cell adhesion mediated by cadherin |
| GO:0051252 | 0.0098 | 2.5764 | 6.7996 | 13 | 3445 | regulation of RNA metabolic process |
| GO:0030046 | 0.0098 | 130.5917 | 0.0099 | 1 | 5 | parallel actin filament bundle assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046534 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of photoreceptor cell differentiation |
| GO:1904158 | 0.0017 | Inf | 0.0017 | 1 | 1 | axonemal central apparatus assembly |
| GO:1904205 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of skeletal muscle hypertrophy |
| GO:0006682 | 0.0034 | 603 | 0.0034 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0010730 | 0.0034 | 603 | 0.0034 | 1 | 2 | negative regulation of hydrogen peroxide biosynthetic process |
| GO:0070682 | 0.0034 | 603 | 0.0034 | 1 | 2 | proteasome regulatory particle assembly |
| GO:2000255 | 0.0051 | 301.4808 | 0.0052 | 1 | 3 | negative regulation of male germ cell proliferation |
| GO:0001895 | 0.0068 | 17.8389 | 0.1238 | 2 | 72 | retina homeostasis |
| GO:1901029 | 0.0086 | 150.7212 | 0.0086 | 1 | 5 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033030 | 0.0029 | 712.8182 | 0.0029 | 1 | 2 | negative regulation of neutrophil apoptotic process |
| GO:1902530 | 0.0029 | 712.8182 | 0.0029 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:0035726 | 0.0088 | 142.5273 | 0.0088 | 1 | 6 | common myeloid progenitor cell proliferation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002779 | 0.001 | Inf | 0.001 | 1 | 1 | antibacterial peptide secretion |
| GO:0051977 | 0.001 | Inf | 0.001 | 1 | 1 | lysophospholipid transport |
| GO:1902530 | 0.002 | 1045.9333 | 0.002 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:0002780 | 0.0041 | 348.6 | 0.0041 | 1 | 4 | antibacterial peptide biosynthetic process |
| GO:0090238 | 0.0051 | 261.4333 | 0.0051 | 1 | 5 | positive regulation of arachidonic acid secretion |
| GO:0090370 | 0.0051 | 261.4333 | 0.0051 | 1 | 5 | negative regulation of cholesterol efflux |
| GO:1903551 | 0.0061 | 209.1333 | 0.0061 | 1 | 6 | regulation of extracellular exosome assembly |
| GO:0002775 | 0.0091 | 130.6833 | 0.0092 | 1 | 9 | antimicrobial peptide production |
| GO:0070424 | 0.0091 | 130.6833 | 0.0092 | 1 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0097341 | 0.0091 | 130.6833 | 0.0092 | 1 | 9 | zymogen inhibition |
| GO:1990001 | 0.0091 | 130.6833 | 0.0092 | 1 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003421 | 0.0013 | Inf | 0.0013 | 1 | 1 | growth plate cartilage axis specification |
| GO:0021541 | 0.0013 | Inf | 0.0013 | 1 | 1 | ammon gyrus development |
| GO:1903403 | 0.0013 | Inf | 0.0013 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:0002408 | 0.0053 | 261.3667 | 0.0053 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0038026 | 0.0053 | 261.3667 | 0.0053 | 1 | 4 | reelin-mediated signaling pathway |
| GO:0031098 | 0.0055 | 9.5154 | 0.365 | 3 | 273 | stress-activated protein kinase signaling cascade |
| GO:0046330 | 0.0094 | 15.1823 | 0.1471 | 2 | 110 | positive regulation of JNK cascade |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006749 | 0 | 58.6388 | 0.0641 | 3 | 53 | glutathione metabolic process |
| GO:1901687 | 6e-04 | 63.5213 | 0.0375 | 2 | 31 | glutathione derivative biosynthetic process |
| GO:0010868 | 0.0024 | 871.4444 | 0.0024 | 1 | 2 | negative regulation of triglyceride biosynthetic process |
| GO:0048211 | 0.0024 | 871.4444 | 0.0024 | 1 | 2 | Golgi vesicle docking |
| GO:0070458 | 0.0036 | 435.6944 | 0.0036 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:0018916 | 0.0048 | 290.4444 | 0.0048 | 1 | 4 | nitrobenzene metabolic process |
| GO:0032792 | 0.006 | 217.8194 | 0.006 | 1 | 5 | negative regulation of CREB transcription factor activity |
| GO:0097264 | 0.0084 | 145.1944 | 0.0085 | 1 | 7 | self proteolysis |
| GO:2000210 | 0.0084 | 145.1944 | 0.0085 | 1 | 7 | positive regulation of anoikis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0021642 | 0.0017 | Inf | 0.0017 | 1 | 1 | trochlear nerve formation |
| GO:0021703 | 0.0017 | Inf | 0.0017 | 1 | 1 | locus ceruleus development |
| GO:0007308 | 0.0033 | 627.16 | 0.0033 | 1 | 2 | oocyte construction |
| GO:0007314 | 0.0033 | 627.16 | 0.0033 | 1 | 2 | oocyte anterior/posterior axis specification |
| GO:0021623 | 0.0033 | 627.16 | 0.0033 | 1 | 2 | oculomotor nerve formation |
| GO:0030719 | 0.0033 | 627.16 | 0.0033 | 1 | 2 | P granule organization |
| GO:0009790 | 0.0046 | 4.5147 | 1.6273 | 6 | 983 | embryo development |
| GO:0010636 | 0.005 | 313.56 | 0.005 | 1 | 3 | positive regulation of mitochondrial fusion |
| GO:0021558 | 0.005 | 313.56 | 0.005 | 1 | 3 | trochlear nerve development |
| GO:0098742 | 0.005 | 9.6553 | 0.3509 | 3 | 212 | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0060415 | 0.0051 | 20.6574 | 0.1076 | 2 | 65 | muscle tissue morphogenesis |
| GO:0021557 | 0.0066 | 209.0267 | 0.0066 | 1 | 4 | oculomotor nerve development |
| GO:0022614 | 0.0066 | 209.0267 | 0.0066 | 1 | 4 | membrane to membrane docking |
| GO:0006306 | 0.009 | 15.2892 | 0.144 | 2 | 87 | DNA methylation |
| GO:0021523 | 0.0099 | 125.4 | 0.0099 | 1 | 6 | somatic motor neuron differentiation |
| GO:0035989 | 0.0099 | 125.4 | 0.0099 | 1 | 6 | tendon development |
| GO:0048743 | 0.0099 | 125.4 | 0.0099 | 1 | 6 | positive regulation of skeletal muscle fiber development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001300 | 0 | 298.6286 | 0.0103 | 2 | 7 | lipoxin metabolic process |
| GO:0019740 | 1e-04 | 248.8413 | 0.0117 | 2 | 8 | nitrogen utilization |
| GO:0019372 | 2e-04 | 135.6883 | 0.019 | 2 | 13 | lipoxygenase pathway |
| GO:0006995 | 2e-04 | 106.5918 | 0.0234 | 2 | 16 | cellular response to nitrogen starvation |
| GO:0015695 | 4e-04 | 82.8836 | 0.0293 | 2 | 20 | organic cation transport |
| GO:0072488 | 6e-04 | 67.7965 | 0.0351 | 2 | 24 | ammonium transmembrane transport |
| GO:0006950 | 0.0011 | 3.9859 | 5.6673 | 13 | 3870 | response to stress |
| GO:0071299 | 0.0015 | Inf | 0.0015 | 1 | 1 | cellular response to vitamin A |
| GO:1901751 | 0.0015 | Inf | 0.0015 | 1 | 1 | leukotriene A4 metabolic process |
| GO:2001306 | 0.0015 | Inf | 0.0015 | 1 | 1 | lipoxin B4 biosynthetic process |
| GO:0031669 | 0.0019 | 13.7698 | 0.2519 | 3 | 172 | cellular response to nutrient levels |
| GO:0046456 | 0.0027 | 29.1914 | 0.0776 | 2 | 53 | icosanoid biosynthetic process |
| GO:0071663 | 0.0029 | 712.8182 | 0.0029 | 1 | 2 | positive regulation of granzyme B production |
| GO:2001303 | 0.0029 | 712.8182 | 0.0029 | 1 | 2 | lipoxin A4 biosynthetic process |
| GO:0019369 | 0.0037 | 24.7984 | 0.0908 | 2 | 62 | arachidonic acid metabolic process |
| GO:0048678 | 0.0039 | 23.9954 | 0.0937 | 2 | 64 | response to axon injury |
| GO:0042322 | 0.0044 | 356.3864 | 0.0044 | 1 | 3 | negative regulation of circadian sleep/wake cycle, REM sleep |
| GO:0060399 | 0.0044 | 356.3864 | 0.0044 | 1 | 3 | positive regulation of growth hormone receptor signaling pathway |
| GO:0072156 | 0.0044 | 356.3864 | 0.0044 | 1 | 3 | distal tubule morphogenesis |
| GO:2000324 | 0.0044 | 356.3864 | 0.0044 | 1 | 3 | positive regulation of glucocorticoid receptor signaling pathway |
| GO:0045927 | 0.0045 | 10.1678 | 0.3383 | 3 | 231 | positive regulation of growth |
| GO:0016525 | 0.0045 | 22.1976 | 0.101 | 2 | 69 | negative regulation of angiogenesis |
| GO:0072376 | 0.0045 | 22.1976 | 0.101 | 2 | 69 | protein activation cascade |
| GO:1901343 | 0.0055 | 20.0888 | 0.1113 | 2 | 76 | negative regulation of vasculature development |
| GO:0030101 | 0.0056 | 19.8197 | 0.1128 | 2 | 77 | natural killer cell activation |
| GO:0032100 | 0.0058 | 237.5758 | 0.0059 | 1 | 4 | positive regulation of appetite |
| GO:0051464 | 0.0058 | 237.5758 | 0.0059 | 1 | 4 | positive regulation of cortisol secretion |
| GO:0070294 | 0.0058 | 237.5758 | 0.0059 | 1 | 4 | renal sodium ion absorption |
| GO:0009991 | 0.0066 | 6.1145 | 0.7703 | 4 | 526 | response to extracellular stimulus |
| GO:0071496 | 0.0072 | 8.5306 | 0.4012 | 3 | 274 | cellular response to external stimulus |
| GO:0048680 | 0.0073 | 178.1705 | 0.0073 | 1 | 5 | positive regulation of axon regeneration |
| GO:0051122 | 0.0073 | 178.1705 | 0.0073 | 1 | 5 | hepoxilin biosynthetic process |
| GO:0051461 | 0.0073 | 178.1705 | 0.0073 | 1 | 5 | positive regulation of corticotropin secretion |
| GO:0042536 | 0.0088 | 142.5273 | 0.0088 | 1 | 6 | negative regulation of tumor necrosis factor biosynthetic process |
| GO:0045409 | 0.0088 | 142.5273 | 0.0088 | 1 | 6 | negative regulation of interleukin-6 biosynthetic process |
| GO:1901568 | 0.0093 | 15.1458 | 0.1464 | 2 | 100 | fatty acid derivative metabolic process |
| GO:0001775 | 0.0097 | 4.4523 | 1.356 | 5 | 926 | cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051216 | 6e-04 | 21.6648 | 0.1738 | 3 | 182 | cartilage development |
| GO:0044273 | 7e-04 | 60.1962 | 0.0401 | 2 | 42 | sulfur compound catabolic process |
| GO:0007601 | 8e-04 | 20.181 | 0.1862 | 3 | 195 | visual perception |
| GO:0060007 | 0.001 | Inf | 0.001 | 1 | 1 | linear vestibuloocular reflex |
| GO:0060618 | 0.001 | Inf | 0.001 | 1 | 1 | nipple development |
| GO:0060649 | 0.001 | Inf | 0.001 | 1 | 1 | mammary gland bud elongation |
| GO:0060659 | 0.001 | Inf | 0.001 | 1 | 1 | nipple sheath formation |
| GO:0002066 | 0.0013 | 43.7371 | 0.0544 | 2 | 57 | columnar/cuboidal epithelial cell development |
| GO:0007189 | 0.0019 | 36.4219 | 0.0649 | 2 | 68 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
| GO:0006535 | 0.0019 | 1120.7143 | 0.0019 | 1 | 2 | cysteine biosynthetic process from serine |
| GO:0043418 | 0.0019 | 1120.7143 | 0.0019 | 1 | 2 | homocysteine catabolic process |
| GO:0071676 | 0.0019 | 1120.7143 | 0.0019 | 1 | 2 | negative regulation of mononuclear cell migration |
| GO:0030819 | 0.0022 | 33.3739 | 0.0707 | 2 | 74 | positive regulation of cAMP biosynthetic process |
| GO:0006565 | 0.0029 | 560.3214 | 0.0029 | 1 | 3 | L-serine catabolic process |
| GO:0019343 | 0.0029 | 560.3214 | 0.0029 | 1 | 3 | cysteine biosynthetic process via cystathionine |
| GO:0019448 | 0.0029 | 560.3214 | 0.0029 | 1 | 3 | L-cysteine catabolic process |
| GO:0036112 | 0.0029 | 560.3214 | 0.0029 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0042262 | 0.0029 | 560.3214 | 0.0029 | 1 | 3 | DNA protection |
| GO:0030810 | 0.0038 | 25.2567 | 0.0926 | 2 | 97 | positive regulation of nucleotide biosynthetic process |
| GO:0019346 | 0.0038 | 373.5238 | 0.0038 | 1 | 4 | transsulfuration |
| GO:0032348 | 0.0038 | 373.5238 | 0.0038 | 1 | 4 | negative regulation of aldosterone biosynthetic process |
| GO:0032914 | 0.0038 | 373.5238 | 0.0038 | 1 | 4 | positive regulation of transforming growth factor beta1 production |
| GO:0070814 | 0.0038 | 373.5238 | 0.0038 | 1 | 4 | hydrogen sulfide biosynthetic process |
| GO:2000065 | 0.0038 | 373.5238 | 0.0038 | 1 | 4 | negative regulation of cortisol biosynthetic process |
| GO:0030801 | 0.0041 | 24.23 | 0.0965 | 2 | 101 | positive regulation of cyclic nucleotide metabolic process |
| GO:0031944 | 0.0048 | 280.125 | 0.0048 | 1 | 5 | negative regulation of glucocorticoid metabolic process |
| GO:0000003 | 0.0055 | 5.6102 | 1.2311 | 5 | 1289 | reproduction |
| GO:0044281 | 0.0056 | 4.5346 | 2.4306 | 7 | 2545 | small molecule metabolic process |
| GO:0021562 | 0.0057 | 224.0857 | 0.0057 | 1 | 6 | vestibulocochlear nerve development |
| GO:0030814 | 0.006 | 19.7966 | 0.1175 | 2 | 123 | regulation of cAMP metabolic process |
| GO:1900544 | 0.0062 | 19.4722 | 0.1194 | 2 | 125 | positive regulation of purine nucleotide metabolic process |
| GO:0030802 | 0.0064 | 19.1582 | 0.1213 | 2 | 127 | regulation of cyclic nucleotide biosynthetic process |
| GO:0031946 | 0.0067 | 186.7262 | 0.0067 | 1 | 7 | regulation of glucocorticoid biosynthetic process |
| GO:0032344 | 0.0067 | 186.7262 | 0.0067 | 1 | 7 | regulation of aldosterone metabolic process |
| GO:1900371 | 0.007 | 18.2736 | 0.127 | 2 | 133 | regulation of purine nucleotide biosynthetic process |
| GO:0031223 | 0.0076 | 160.0408 | 0.0076 | 1 | 8 | auditory behavior |
| GO:0032353 | 0.0076 | 160.0408 | 0.0076 | 1 | 8 | negative regulation of hormone biosynthetic process |
| GO:0043569 | 0.0076 | 160.0408 | 0.0076 | 1 | 8 | negative regulation of insulin-like growth factor receptor signaling pathway |
| GO:0044703 | 0.0083 | 6.1129 | 0.8452 | 4 | 885 | multi-organism reproductive process |
| GO:0052652 | 0.0084 | 16.4944 | 0.1404 | 2 | 147 | cyclic purine nucleotide metabolic process |
| GO:0010566 | 0.0086 | 140.0268 | 0.0086 | 1 | 9 | regulation of ketone biosynthetic process |
| GO:0034650 | 0.0086 | 140.0268 | 0.0086 | 1 | 9 | cortisol metabolic process |
| GO:0046661 | 0.0088 | 16.157 | 0.1433 | 2 | 150 | male sex differentiation |
| GO:0006600 | 0.0095 | 124.4603 | 0.0096 | 1 | 10 | creatine metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030097 | 7e-04 | 8.869 | 0.7674 | 5 | 709 | hemopoiesis |
| GO:0050913 | 8e-04 | 56.4036 | 0.0422 | 2 | 39 | sensory perception of bitter taste |
| GO:0002573 | 9e-04 | 18.5674 | 0.197 | 3 | 182 | myeloid leukocyte differentiation |
| GO:0002668 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of T cell anergy |
| GO:0032681 | 0.0011 | Inf | 0.0011 | 1 | 1 | regulation of lymphotoxin A production |
| GO:0035038 | 0.0011 | Inf | 0.0011 | 1 | 1 | female pronucleus assembly |
| GO:0035644 | 0.0011 | Inf | 0.0011 | 1 | 1 | phosphoanandamide dephosphorylation |
| GO:0043017 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of lymphotoxin A biosynthetic process |
| GO:0002520 | 0.0012 | 7.8164 | 0.8648 | 5 | 799 | immune system development |
| GO:0002366 | 0.0013 | 16.5954 | 0.2197 | 3 | 203 | leukocyte activation involved in immune response |
| GO:0002644 | 0.0022 | 980.5 | 0.0022 | 1 | 2 | negative regulation of tolerance induction |
| GO:0045404 | 0.0022 | 980.5 | 0.0022 | 1 | 2 | positive regulation of interleukin-4 biosynthetic process |
| GO:1902523 | 0.0022 | 980.5 | 0.0022 | 1 | 2 | positive regulation of protein K63-linked ubiquitination |
| GO:0046651 | 0.0023 | 13.3419 | 0.2717 | 3 | 251 | lymphocyte proliferation |
| GO:0014823 | 0.0026 | 30.6294 | 0.0758 | 2 | 70 | response to activity |
| GO:0070661 | 0.0027 | 12.5687 | 0.2879 | 3 | 266 | leukocyte proliferation |
| GO:0030101 | 0.0031 | 27.7582 | 0.0833 | 2 | 77 | natural killer cell activation |
| GO:0042427 | 0.0032 | 490.2188 | 0.0032 | 1 | 3 | serotonin biosynthetic process |
| GO:0070433 | 0.0032 | 490.2188 | 0.0032 | 1 | 3 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:1900194 | 0.0032 | 490.2188 | 0.0032 | 1 | 3 | negative regulation of oocyte maturation |
| GO:0002682 | 0.0034 | 5.2761 | 1.5976 | 6 | 1476 | regulation of immune system process |
| GO:0060337 | 0.0035 | 26.015 | 0.0888 | 2 | 82 | type I interferon signaling pathway |
| GO:0034340 | 0.0038 | 24.7698 | 0.0931 | 2 | 86 | response to type I interferon |
| GO:0030098 | 0.0039 | 11.0296 | 0.3269 | 3 | 302 | lymphocyte differentiation |
| GO:0046219 | 0.0043 | 326.7917 | 0.0043 | 1 | 4 | indolalkylamine biosynthetic process |
| GO:1903753 | 0.0043 | 326.7917 | 0.0043 | 1 | 4 | negative regulation of p38MAPK cascade |
| GO:2000483 | 0.0043 | 326.7917 | 0.0043 | 1 | 4 | negative regulation of interleukin-8 secretion |
| GO:0051607 | 0.0049 | 10.1942 | 0.3529 | 3 | 326 | defense response to virus |
| GO:0002309 | 0.0054 | 245.0781 | 0.0054 | 1 | 5 | T cell proliferation involved in immune response |
| GO:0008588 | 0.0054 | 245.0781 | 0.0054 | 1 | 5 | release of cytoplasmic sequestered NF-kappaB |
| GO:0032571 | 0.0054 | 245.0781 | 0.0054 | 1 | 5 | response to vitamin K |
| GO:0033594 | 0.0054 | 245.0781 | 0.0054 | 1 | 5 | response to hydroxyisoflavone |
| GO:0071225 | 0.0054 | 245.0781 | 0.0054 | 1 | 5 | cellular response to muramyl dipeptide |
| GO:0071706 | 0.0055 | 20.3752 | 0.1126 | 2 | 104 | tumor necrosis factor superfamily cytokine production |
| GO:1903715 | 0.0065 | 196.05 | 0.0065 | 1 | 6 | regulation of aerobic respiration |
| GO:0002911 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | regulation of lymphocyte anergy |
| GO:0034141 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | positive regulation of toll-like receptor 3 signaling pathway |
| GO:0045630 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | positive regulation of T-helper 2 cell differentiation |
| GO:0060631 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | regulation of meiosis I |
| GO:1900165 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | negative regulation of interleukin-6 secretion |
| GO:0071901 | 0.0078 | 17.0131 | 0.1342 | 2 | 124 | negative regulation of protein serine/threonine kinase activity |
| GO:0031347 | 0.0082 | 5.9862 | 0.8345 | 4 | 771 | regulation of defense response |
| GO:0032817 | 0.0086 | 140.0179 | 0.0087 | 1 | 8 | regulation of natural killer cell proliferation |
| GO:1902715 | 0.0086 | 140.0179 | 0.0087 | 1 | 8 | positive regulation of interferon-gamma secretion |
| GO:0042326 | 0.0095 | 7.926 | 0.4503 | 3 | 416 | negative regulation of phosphorylation |
| GO:0071248 | 0.0096 | 15.248 | 0.1494 | 2 | 138 | cellular response to metal ion |
| GO:0010388 | 0.0097 | 122.5078 | 0.0097 | 1 | 9 | cullin deneddylation |
| GO:0060281 | 0.0097 | 122.5078 | 0.0097 | 1 | 9 | regulation of oocyte development |
| GO:0070424 | 0.0097 | 122.5078 | 0.0097 | 1 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031295 | 3e-04 | 25.7258 | 0.1348 | 3 | 73 | T cell costimulation |
| GO:0002062 | 7e-04 | 19.1281 | 0.1791 | 3 | 97 | chondrocyte differentiation |
| GO:0032673 | 0.001 | 50.4155 | 0.0462 | 2 | 25 | regulation of interleukin-4 production |
| GO:0002668 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of T cell anergy |
| GO:0032203 | 0.0018 | Inf | 0.0018 | 1 | 1 | telomere formation via telomerase |
| GO:0032681 | 0.0018 | Inf | 0.0018 | 1 | 1 | regulation of lymphotoxin A production |
| GO:0043017 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of lymphotoxin A biosynthetic process |
| GO:1990079 | 0.0018 | Inf | 0.0018 | 1 | 1 | cartilage homeostasis |
| GO:0048522 | 0.0026 | 3.0493 | 8.3532 | 16 | 4524 | positive regulation of cellular process |
| GO:0034341 | 0.003 | 11.6306 | 0.2899 | 3 | 157 | response to interferon-gamma |
| GO:0050852 | 0.003 | 11.6306 | 0.2899 | 3 | 157 | T cell receptor signaling pathway |
| GO:0002478 | 0.0035 | 10.9144 | 0.3084 | 3 | 167 | antigen processing and presentation of exogenous peptide antigen |
| GO:0002644 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | negative regulation of tolerance induction |
| GO:0014846 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | esophagus smooth muscle contraction |
| GO:0045404 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | positive regulation of interleukin-4 biosynthetic process |
| GO:0007032 | 0.0058 | 19.2802 | 0.1145 | 2 | 62 | endosome organization |
| GO:0034112 | 0.0058 | 9.0668 | 0.3693 | 3 | 200 | positive regulation of homotypic cell-cell adhesion |
| GO:1903039 | 0.006 | 8.9745 | 0.373 | 3 | 202 | positive regulation of leukocyte cell-cell adhesion |
| GO:0060686 | 0.0074 | 186.5952 | 0.0074 | 1 | 4 | negative regulation of prostatic bud formation |
| GO:0090666 | 0.0074 | 186.5952 | 0.0074 | 1 | 4 | scaRNA localization to Cajal body |
| GO:0042110 | 0.0078 | 5.7006 | 0.7977 | 4 | 432 | T cell activation |
| GO:0071593 | 0.0078 | 5.6869 | 0.7995 | 4 | 433 | lymphocyte aggregation |
| GO:0019882 | 0.0081 | 8.0327 | 0.4154 | 3 | 225 | antigen processing and presentation |
| GO:0002757 | 0.0087 | 5.5149 | 0.8235 | 4 | 446 | immune response-activating signal transduction |
| GO:0061448 | 0.0089 | 7.7493 | 0.4302 | 3 | 233 | connective tissue development |
| GO:0006595 | 0.0091 | 15.2057 | 0.144 | 2 | 78 | polyamine metabolic process |
| GO:0002309 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | T cell proliferation involved in immune response |
| GO:0008588 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | release of cytoplasmic sequestered NF-kappaB |
| GO:0042760 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | very long-chain fatty acid catabolic process |
| GO:0007034 | 0.01 | 14.4417 | 0.1514 | 2 | 82 | vacuolar transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0010226 | 6e-04 | 68.2353 | 0.0351 | 2 | 29 | response to lithium ion |
| GO:0050911 | 9e-04 | 11.0699 | 0.4512 | 4 | 373 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0097275 | 0.0012 | Inf | 0.0012 | 1 | 1 | cellular ammonia homeostasis |
| GO:0097276 | 0.0012 | Inf | 0.0012 | 1 | 1 | cellular creatinine homeostasis |
| GO:0097277 | 0.0012 | Inf | 0.0012 | 1 | 1 | cellular urea homeostasis |
| GO:0009593 | 0.0019 | 9.0293 | 0.5492 | 4 | 454 | detection of chemical stimulus |
| GO:0003407 | 0.0021 | 34.0588 | 0.0677 | 2 | 56 | neural retina development |
| GO:0007606 | 0.0021 | 8.7683 | 0.5649 | 4 | 467 | sensory perception of chemical stimulus |
| GO:0050906 | 0.0021 | 8.7683 | 0.5649 | 4 | 467 | detection of stimulus involved in sensory perception |
| GO:0050877 | 0.0024 | 5.5171 | 1.4722 | 6 | 1217 | neurological system process |
| GO:0006682 | 0.0024 | 871.4444 | 0.0024 | 1 | 2 | galactosylceramide biosynthetic process |
| GO:0097332 | 0.0036 | 435.6944 | 0.0036 | 1 | 3 | response to antipsychotic drug |
| GO:0060024 | 0.0048 | 290.4444 | 0.0048 | 1 | 4 | rhythmic synaptic transmission |
| GO:0003279 | 0.0057 | 19.9425 | 0.1137 | 2 | 94 | cardiac septum development |
| GO:0019374 | 0.0072 | 174.2444 | 0.0073 | 1 | 6 | galactolipid metabolic process |
| GO:0097070 | 0.0072 | 174.2444 | 0.0073 | 1 | 6 | ductus arteriosus closure |
| GO:0071670 | 0.0084 | 145.1944 | 0.0085 | 1 | 7 | smooth muscle cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071285 | 4e-04 | 80.1228 | 0.0302 | 2 | 19 | cellular response to lithium ion |
| GO:1901687 | 0.0011 | 46.9325 | 0.0493 | 2 | 31 | glutathione derivative biosynthetic process |
| GO:0008207 | 0.0012 | 43.899 | 0.0525 | 2 | 33 | C21-steroid hormone metabolic process |
| GO:0032078 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:0034230 | 0.0016 | Inf | 0.0016 | 1 | 1 | enkephalin processing |
| GO:0034231 | 0.0016 | Inf | 0.0016 | 1 | 1 | islet amyloid polypeptide processing |
| GO:0042445 | 0.0029 | 11.8767 | 0.2881 | 3 | 181 | hormone metabolic process |
| GO:0071344 | 0.0032 | 653.3333 | 0.0032 | 1 | 2 | diphosphate metabolic process |
| GO:0071676 | 0.0032 | 653.3333 | 0.0032 | 1 | 2 | negative regulation of mononuclear cell migration |
| GO:0006749 | 0.0032 | 26.6496 | 0.0844 | 2 | 53 | glutathione metabolic process |
| GO:0030070 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | insulin processing |
| GO:0032074 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | negative regulation of nuclease activity |
| GO:0042427 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | serotonin biosynthetic process |
| GO:0044375 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | regulation of peroxisome size |
| GO:0070458 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:0097332 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | response to antipsychotic drug |
| GO:0043627 | 0.0048 | 9.8558 | 0.3454 | 3 | 217 | response to estrogen |
| GO:0014823 | 0.0055 | 19.9655 | 0.1114 | 2 | 70 | response to activity |
| GO:0002943 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | tRNA dihydrouridine synthesis |
| GO:0016557 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | peroxisome membrane biogenesis |
| GO:0018916 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | nitrobenzene metabolic process |
| GO:0032348 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | negative regulation of aldosterone biosynthetic process |
| GO:0046219 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | indolalkylamine biosynthetic process |
| GO:2000065 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | negative regulation of cortisol biosynthetic process |
| GO:0098754 | 0.0071 | 17.3946 | 0.1273 | 2 | 80 | detoxification |
| GO:0031944 | 0.0079 | 163.3021 | 0.008 | 1 | 5 | negative regulation of glucocorticoid metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0071346 | 5e-04 | 23.391 | 0.1559 | 3 | 136 | cellular response to interferon-gamma |
| GO:0007156 | 6e-04 | 21 | 0.1731 | 3 | 151 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0070374 | 9e-04 | 18.7012 | 0.1937 | 3 | 169 | positive regulation of ERK1 and ERK2 cascade |
| GO:0051977 | 0.0011 | Inf | 0.0011 | 1 | 1 | lysophospholipid transport |
| GO:0048247 | 0.0015 | 40.7292 | 0.0573 | 2 | 50 | lymphocyte chemotaxis |
| GO:0002548 | 0.002 | 34.2785 | 0.0676 | 2 | 59 | monocyte chemotaxis |
| GO:0043420 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | anthranilate metabolic process |
| GO:0070098 | 0.0036 | 25.3425 | 0.0905 | 2 | 79 | chemokine-mediated signaling pathway |
| GO:0030593 | 0.0043 | 23.2202 | 0.0986 | 2 | 86 | neutrophil chemotaxis |
| GO:0019805 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | quinolinate biosynthetic process |
| GO:0034354 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | 'de novo' NAD biosynthetic process from tryptophan |
| GO:0071347 | 0.0047 | 22.1591 | 0.1031 | 2 | 90 | cellular response to interleukin-1 |
| GO:0090238 | 0.0057 | 230.6471 | 0.0057 | 1 | 5 | positive regulation of arachidonic acid secretion |
| GO:0090370 | 0.0057 | 230.6471 | 0.0057 | 1 | 5 | negative regulation of cholesterol efflux |
| GO:0016198 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | axon choice point recognition |
| GO:0097530 | 0.0069 | 18.0324 | 0.1261 | 2 | 110 | granulocyte migration |
| GO:0050729 | 0.0072 | 17.7023 | 0.1284 | 2 | 112 | positive regulation of inflammatory response |
| GO:0019441 | 0.008 | 153.7451 | 0.008 | 1 | 7 | tryptophan catabolic process to kynurenine |
| GO:0008037 | 0.0097 | 15.0766 | 0.1501 | 2 | 131 | cell recognition |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050928 | 9e-04 | Inf | 9e-04 | 1 | 1 | negative regulation of positive chemotaxis |
| GO:0071299 | 9e-04 | Inf | 9e-04 | 1 | 1 | cellular response to vitamin A |
| GO:0072274 | 9e-04 | Inf | 9e-04 | 1 | 1 | metanephric glomerular basement membrane development |
| GO:0032835 | 0.0011 | 47.3848 | 0.0508 | 2 | 57 | glomerulus development |
| GO:0048678 | 0.0014 | 42.0161 | 0.057 | 2 | 64 | response to axon injury |
| GO:0052565 | 0.0018 | 1207 | 0.0018 | 1 | 2 | response to defense-related host nitric oxide production |
| GO:0048014 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | Tie signaling pathway |
| GO:0048677 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | axon extension involved in regeneration |
| GO:0072249 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | metanephric glomerular visceral epithelial cell development |
| GO:0072312 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | metanephric glomerular epithelial cell differentiation |
| GO:0043137 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | DNA replication, removal of RNA primer |
| GO:0052564 | 0.0053 | 241.3385 | 0.0053 | 1 | 6 | response to immune response of other organism involved in symbiotic interaction |
| GO:0052200 | 0.0062 | 201.1026 | 0.0062 | 1 | 7 | response to host defenses |
| GO:2001300 | 0.0062 | 201.1026 | 0.0062 | 1 | 7 | lipoxin metabolic process |
| GO:0051707 | 0.0066 | 6.6368 | 0.7987 | 4 | 896 | response to other organism |
| GO:0006273 | 0.0071 | 172.3626 | 0.0071 | 1 | 8 | lagging strand elongation |
| GO:0060087 | 0.0071 | 172.3626 | 0.0071 | 1 | 8 | relaxation of vascular smooth muscle |
| GO:0009607 | 0.0076 | 6.3638 | 0.8308 | 4 | 932 | response to biotic stimulus |
| GO:0009635 | 0.0089 | 134.0427 | 0.0089 | 1 | 10 | response to herbicide |
| GO:0072310 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | glomerular epithelial cell development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032970 | 7e-04 | 11.6327 | 0.4174 | 4 | 298 | regulation of actin filament-based process |
| GO:0003421 | 0.0014 | Inf | 0.0014 | 1 | 1 | growth plate cartilage axis specification |
| GO:0043538 | 0.0014 | Inf | 0.0014 | 1 | 1 | regulation of actin phosphorylation |
| GO:1903403 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of renal phosphate excretion |
| GO:0030047 | 0.0042 | 373.381 | 0.0042 | 1 | 3 | actin modification |
| GO:0042427 | 0.0042 | 373.381 | 0.0042 | 1 | 3 | serotonin biosynthetic process |
| GO:0002408 | 0.0056 | 248.9048 | 0.0056 | 1 | 4 | myeloid dendritic cell chemotaxis |
| GO:0006021 | 0.0056 | 248.9048 | 0.0056 | 1 | 4 | inositol biosynthetic process |
| GO:0046219 | 0.0056 | 248.9048 | 0.0056 | 1 | 4 | indolalkylamine biosynthetic process |
| GO:0042989 | 0.007 | 186.6667 | 0.007 | 1 | 5 | sequestering of actin monomers |
| GO:0007015 | 0.0083 | 8.0968 | 0.4244 | 3 | 303 | actin filament organization |
| GO:0009249 | 0.0084 | 149.3238 | 0.0084 | 1 | 6 | protein lipoylation |
| GO:0006342 | 0.0095 | 14.9808 | 0.1485 | 2 | 106 | chromatin silencing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046356 | 0.0013 | Inf | 0.0013 | 1 | 1 | acetyl-CoA catabolic process |
| GO:0051977 | 0.0013 | Inf | 0.0013 | 1 | 1 | lysophospholipid transport |
| GO:0044712 | 0.0017 | 5.8956 | 1.3613 | 6 | 1069 | single-organism catabolic process |
| GO:0006535 | 0.0025 | 825.5263 | 0.0025 | 1 | 2 | cysteine biosynthetic process from serine |
| GO:0015938 | 0.0025 | 825.5263 | 0.0025 | 1 | 2 | coenzyme A catabolic process |
| GO:0033869 | 0.0025 | 825.5263 | 0.0025 | 1 | 2 | nucleoside bisphosphate catabolic process |
| GO:0043418 | 0.0025 | 825.5263 | 0.0025 | 1 | 2 | homocysteine catabolic process |
| GO:0016054 | 0.0026 | 12.5213 | 0.2814 | 3 | 221 | organic acid catabolic process |
| GO:0006565 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | L-serine catabolic process |
| GO:0019343 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | cysteine biosynthetic process via cystathionine |
| GO:0019448 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | L-cysteine catabolic process |
| GO:0042262 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | DNA protection |
| GO:0043420 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | anthranilate metabolic process |
| GO:0010992 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | ubiquitin homeostasis |
| GO:0019346 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | transsulfuration |
| GO:0019805 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | quinolinate biosynthetic process |
| GO:0034354 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | 'de novo' NAD biosynthetic process from tryptophan |
| GO:0070814 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | hydrogen sulfide biosynthetic process |
| GO:0006575 | 0.0062 | 9.1125 | 0.3833 | 3 | 301 | cellular modified amino acid metabolic process |
| GO:0010756 | 0.0064 | 206.3421 | 0.0064 | 1 | 5 | positive regulation of plasminogen activation |
| GO:0042760 | 0.0064 | 206.3421 | 0.0064 | 1 | 5 | very long-chain fatty acid catabolic process |
| GO:0090238 | 0.0064 | 206.3421 | 0.0064 | 1 | 5 | positive regulation of arachidonic acid secretion |
| GO:0090370 | 0.0064 | 206.3421 | 0.0064 | 1 | 5 | negative regulation of cholesterol efflux |
| GO:0050684 | 0.0065 | 18.4303 | 0.1222 | 2 | 96 | regulation of mRNA processing |
| GO:0008063 | 0.0076 | 165.0632 | 0.0076 | 1 | 6 | Toll signaling pathway |
| GO:1901605 | 0.0082 | 8.2118 | 0.424 | 3 | 333 | alpha-amino acid metabolic process |
| GO:0019441 | 0.0089 | 137.5439 | 0.0089 | 1 | 7 | tryptophan catabolic process to kynurenine |
| GO:0060054 | 0.0089 | 137.5439 | 0.0089 | 1 | 7 | positive regulation of epithelial cell proliferation involved in wound healing |
| GO:0090091 | 0.0089 | 137.5439 | 0.0089 | 1 | 7 | positive regulation of extracellular matrix disassembly |
| GO:0009063 | 0.0096 | 15.0444 | 0.149 | 2 | 117 | cellular amino acid catabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000387 | 0.0018 | 35.7963 | 0.0637 | 2 | 40 | spliceosomal snRNP assembly |
| GO:0007618 | 0.0022 | 32.3789 | 0.07 | 2 | 44 | mating |
| GO:0035039 | 0.0032 | 653.3333 | 0.0032 | 1 | 2 | male pronucleus assembly |
| GO:1904211 | 0.0032 | 653.3333 | 0.0032 | 1 | 2 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol |
| GO:0000245 | 0.0032 | 26.6496 | 0.0844 | 2 | 53 | spliceosomal complex assembly |
| GO:0006749 | 0.0032 | 26.6496 | 0.0844 | 2 | 53 | glutathione metabolic process |
| GO:0000720 | 0.0048 | 326.6458 | 0.0048 | 1 | 3 | pyrimidine dimer repair by nucleotide-excision repair |
| GO:0007621 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | negative regulation of female receptivity |
| GO:0031117 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | positive regulation of microtubule depolymerization |
| GO:0048597 | 0.0064 | 217.75 | 0.0064 | 1 | 4 | post-embryonic camera-type eye morphogenesis |
| GO:0042221 | 0.0065 | 2.9556 | 6.7156 | 13 | 4219 | response to chemical |
| GO:0030593 | 0.0082 | 16.146 | 0.1369 | 2 | 86 | neutrophil chemotaxis |
| GO:0008063 | 0.0095 | 130.6333 | 0.0096 | 1 | 6 | Toll signaling pathway |
| GO:0070459 | 0.0095 | 130.6333 | 0.0096 | 1 | 6 | prolactin secretion |
| GO:0006353 | 0.0097 | 14.7344 | 0.1496 | 2 | 94 | DNA-templated transcription, termination |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016339 | 6e-04 | 64.4403 | 0.0369 | 2 | 29 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0007156 | 9e-04 | 18.527 | 0.1923 | 3 | 151 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0022610 | 0.0012 | 5.5206 | 1.784 | 7 | 1401 | biological adhesion |
| GO:0015747 | 0.0038 | 412.7368 | 0.0038 | 1 | 3 | urate transport |
| GO:0098609 | 0.0039 | 5.7465 | 1.1015 | 5 | 865 | cell-cell adhesion |
| GO:0015760 | 0.0051 | 275.1404 | 0.0051 | 1 | 4 | glucose-6-phosphate transport |
| GO:1903825 | 0.006 | 19.2543 | 0.1172 | 2 | 92 | organic acid transmembrane transport |
| GO:0008627 | 0.0064 | 206.3421 | 0.0064 | 1 | 5 | intrinsic apoptotic signaling pathway in response to osmotic stress |
| GO:0098661 | 0.0067 | 18.2351 | 0.1235 | 2 | 97 | inorganic anion transmembrane transport |
| GO:0035965 | 0.0076 | 165.0632 | 0.0076 | 1 | 6 | cardiolipin acyl-chain remodeling |
| GO:0007268 | 0.0099 | 5.5169 | 0.871 | 4 | 684 | synaptic transmission |
| GO:0099536 | 0.0099 | 5.5169 | 0.871 | 4 | 684 | synaptic signaling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019402 | 0.0018 | Inf | 0.0018 | 1 | 1 | galactitol metabolic process |
| GO:0019731 | 0.0036 | 25.0481 | 0.0891 | 2 | 50 | antibacterial humoral response |
| GO:0002337 | 0.0036 | 580.6296 | 0.0036 | 1 | 2 | B-1a B cell differentiation |
| GO:0048211 | 0.0036 | 580.6296 | 0.0036 | 1 | 2 | Golgi vesicle docking |
| GO:1901318 | 0.0036 | 580.6296 | 0.0036 | 1 | 2 | negative regulation of sperm motility |
| GO:0008065 | 0.0053 | 290.2963 | 0.0053 | 1 | 3 | establishment of blood-nerve barrier |
| GO:0070458 | 0.0053 | 290.2963 | 0.0053 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:1900005 | 0.0053 | 290.2963 | 0.0053 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:0018916 | 0.0071 | 193.5185 | 0.0071 | 1 | 4 | nitrobenzene metabolic process |
| GO:0001895 | 0.0073 | 17.1516 | 0.1284 | 2 | 72 | retina homeostasis |
| GO:0044706 | 0.0087 | 7.8182 | 0.4279 | 3 | 240 | multi-multicellular organism process |
| GO:0002322 | 0.0089 | 145.1296 | 0.0089 | 1 | 5 | B cell proliferation involved in immune response |
| GO:0050859 | 0.0089 | 145.1296 | 0.0089 | 1 | 5 | negative regulation of B cell receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060618 | 8e-04 | Inf | 8e-04 | 1 | 1 | nipple development |
| GO:0060649 | 8e-04 | Inf | 8e-04 | 1 | 1 | mammary gland bud elongation |
| GO:0060659 | 8e-04 | Inf | 8e-04 | 1 | 1 | nipple sheath formation |
| GO:0006535 | 0.0015 | 1426.6364 | 0.0015 | 1 | 2 | cysteine biosynthetic process from serine |
| GO:0019343 | 0.0023 | 713.2727 | 0.0023 | 1 | 3 | cysteine biosynthetic process via cystathionine |
| GO:0036112 | 0.0023 | 713.2727 | 0.0023 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0006289 | 0.0032 | 28.3345 | 0.0856 | 2 | 112 | nucleotide-excision repair |
| GO:0045814 | 0.0058 | 20.5868 | 0.1169 | 2 | 153 | negative regulation of gene expression, epigenetic |
| GO:0019227 | 0.0061 | 203.7273 | 0.0061 | 1 | 8 | neuronal action potential propagation |
| GO:0006534 | 0.0076 | 158.4343 | 0.0076 | 1 | 10 | cysteine metabolic process |
| GO:0043129 | 0.0091 | 129.6116 | 0.0092 | 1 | 12 | surfactant homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060618 | 0.001 | Inf | 0.001 | 1 | 1 | nipple development |
| GO:0060649 | 0.001 | Inf | 0.001 | 1 | 1 | mammary gland bud elongation |
| GO:0060659 | 0.001 | Inf | 0.001 | 1 | 1 | nipple sheath formation |
| GO:0036112 | 0.0031 | 522.9333 | 0.0031 | 1 | 3 | medium-chain fatty-acyl-CoA metabolic process |
| GO:0030817 | 0.0052 | 21.2041 | 0.109 | 2 | 107 | regulation of cAMP biosynthetic process |
| GO:0048539 | 0.0061 | 209.1333 | 0.0061 | 1 | 6 | bone marrow development |
| GO:2000766 | 0.0061 | 209.1333 | 0.0061 | 1 | 6 | negative regulation of cytoplasmic translation |
| GO:0007196 | 0.0071 | 174.2667 | 0.0071 | 1 | 7 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GO:0030808 | 0.0079 | 16.9673 | 0.1355 | 2 | 133 | regulation of nucleotide biosynthetic process |
| GO:0007188 | 0.0088 | 15.9825 | 0.1436 | 2 | 141 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0046058 | 0.0096 | 15.3153 | 0.1498 | 2 | 147 | cAMP metabolic process |
| GO:0052652 | 0.0096 | 15.3153 | 0.1498 | 2 | 147 | cyclic purine nucleotide metabolic process |
| GO:0030799 | 0.0098 | 15.105 | 0.1518 | 2 | 149 | regulation of cyclic nucleotide metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019740 | 0 | 348.5111 | 0.0087 | 2 | 8 | nitrogen utilization |
| GO:0006995 | 1e-04 | 149.2857 | 0.0173 | 2 | 16 | cellular response to nitrogen starvation |
| GO:0015695 | 2e-04 | 116.0815 | 0.0216 | 2 | 20 | organic cation transport |
| GO:0072488 | 3e-04 | 94.9515 | 0.026 | 2 | 24 | ammonium transmembrane transport |
| GO:0007344 | 0.0011 | Inf | 0.0011 | 1 | 1 | pronuclear fusion |
| GO:0060007 | 0.0011 | Inf | 0.0011 | 1 | 1 | linear vestibuloocular reflex |
| GO:0014038 | 0.0032 | 490.2188 | 0.0032 | 1 | 3 | regulation of Schwann cell differentiation |
| GO:0030098 | 0.0039 | 11.0296 | 0.3269 | 3 | 302 | lymphocyte differentiation |
| GO:0022614 | 0.0043 | 326.7917 | 0.0043 | 1 | 4 | membrane to membrane docking |
| GO:0032609 | 0.0052 | 20.9966 | 0.1093 | 2 | 101 | interferon-gamma production |
| GO:0046631 | 0.0058 | 19.7892 | 0.1158 | 2 | 107 | alpha-beta T cell activation |
| GO:0021562 | 0.0065 | 196.05 | 0.0065 | 1 | 6 | vestibulocochlear nerve development |
| GO:0090166 | 0.0065 | 196.05 | 0.0065 | 1 | 6 | Golgi disassembly |
| GO:0001865 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | NK T cell differentiation |
| GO:0060710 | 0.0076 | 163.3646 | 0.0076 | 1 | 7 | chorio-allantoic fusion |
| GO:0031223 | 0.0086 | 140.0179 | 0.0087 | 1 | 8 | auditory behavior |
| GO:0045471 | 0.0088 | 15.9579 | 0.1429 | 2 | 132 | response to ethanol |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000964 | 0.0018 | 1207 | 0.0018 | 1 | 2 | mitochondrial RNA 5'-end processing |
| GO:1902530 | 0.0018 | 1207 | 0.0018 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:1901509 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | regulation of endothelial tube morphogenesis |
| GO:1901740 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | negative regulation of myoblast fusion |
| GO:0019243 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione |
| GO:0051596 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | methylglyoxal catabolic process |
| GO:0090646 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | mitochondrial tRNA processing |
| GO:0019249 | 0.0044 | 301.6923 | 0.0045 | 1 | 5 | lactate biosynthetic process |
| GO:0030046 | 0.0044 | 301.6923 | 0.0045 | 1 | 5 | parallel actin filament bundle assembly |
| GO:0050957 | 0.0071 | 172.3626 | 0.0071 | 1 | 8 | equilibrioception |
| GO:0070900 | 0.0071 | 172.3626 | 0.0071 | 1 | 8 | mitochondrial tRNA modification |
| GO:0070424 | 0.008 | 150.8077 | 0.008 | 1 | 9 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0097341 | 0.008 | 150.8077 | 0.008 | 1 | 9 | zymogen inhibition |
| GO:1990001 | 0.008 | 150.8077 | 0.008 | 1 | 9 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0042118 | 0.0089 | 134.0427 | 0.0089 | 1 | 10 | endothelial cell activation |
| GO:0010819 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | regulation of T cell chemotaxis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000042 | 6e-04 | 65.2417 | 0.0367 | 2 | 18 | protein targeting to Golgi |
| GO:0007344 | 0.002 | Inf | 0.002 | 1 | 1 | pronuclear fusion |
| GO:1901986 | 0.002 | Inf | 0.002 | 1 | 1 | response to ketamine |
| GO:1904010 | 0.002 | Inf | 0.002 | 1 | 1 | response to Aroclor 1254 |
| GO:0030803 | 0.0027 | 28.9593 | 0.0774 | 2 | 38 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:1900372 | 0.003 | 27.4316 | 0.0815 | 2 | 40 | negative regulation of purine nucleotide biosynthetic process |
| GO:0006891 | 0.0034 | 25.4195 | 0.0876 | 2 | 43 | intra-Golgi vesicle-mediated transport |
| GO:0021568 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | rhombomere 2 development |
| GO:0021658 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | rhombomere 3 morphogenesis |
| GO:0031283 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | negative regulation of guanylate cyclase activity |
| GO:0033030 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | negative regulation of neutrophil apoptotic process |
| GO:1902530 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | positive regulation of protein linear polyubiquitination |
| GO:1904009 | 0.0041 | 505.5806 | 0.0041 | 1 | 2 | cellular response to monosodium glutamate |
| GO:0006887 | 0.0053 | 6.3287 | 0.7131 | 4 | 350 | exocytosis |
| GO:0014038 | 0.0061 | 252.7742 | 0.0061 | 1 | 3 | regulation of Schwann cell differentiation |
| GO:0030047 | 0.0061 | 252.7742 | 0.0061 | 1 | 3 | actin modification |
| GO:0030824 | 0.0061 | 252.7742 | 0.0061 | 1 | 3 | negative regulation of cGMP metabolic process |
| GO:0033693 | 0.0061 | 252.7742 | 0.0061 | 1 | 3 | neurofilament bundle assembly |
| GO:0035284 | 0.0061 | 252.7742 | 0.0061 | 1 | 3 | brain segmentation |
| GO:0045761 | 0.0075 | 16.7871 | 0.1304 | 2 | 64 | regulation of adenylate cyclase activity |
| GO:0045980 | 0.008 | 16.2604 | 0.1345 | 2 | 66 | negative regulation of nucleotide metabolic process |
| GO:0016080 | 0.0081 | 168.5054 | 0.0081 | 1 | 4 | synaptic vesicle targeting |
| GO:0033634 | 0.0081 | 168.5054 | 0.0081 | 1 | 4 | positive regulation of cell-cell adhesion mediated by integrin |
| GO:0034599 | 0.0098 | 7.4033 | 0.4462 | 3 | 219 | cellular response to oxidative stress |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001894 | 8e-04 | 20.5022 | 0.1863 | 3 | 209 | tissue homeostasis |
| GO:0007344 | 9e-04 | Inf | 9e-04 | 1 | 1 | pronuclear fusion |
| GO:0060764 | 0.0018 | 1207 | 0.0018 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0046849 | 0.002 | 35.1757 | 0.0677 | 2 | 76 | bone remodeling |
| GO:0014038 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | regulation of Schwann cell differentiation |
| GO:0060435 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | bronchiole development |
| GO:1902714 | 0.0027 | 603.4615 | 0.0027 | 1 | 3 | negative regulation of interferon-gamma secretion |
| GO:0032649 | 0.0029 | 29.2191 | 0.0811 | 2 | 91 | regulation of interferon-gamma production |
| GO:0060480 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | lung goblet cell differentiation |
| GO:0060535 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | trachea cartilage morphogenesis |
| GO:0060574 | 0.0036 | 402.2821 | 0.0036 | 1 | 4 | intestinal epithelial cell maturation |
| GO:0060482 | 0.0053 | 241.3385 | 0.0053 | 1 | 6 | lobar bronchus development |
| GO:0090166 | 0.0053 | 241.3385 | 0.0053 | 1 | 6 | Golgi disassembly |
| GO:0045647 | 0.0062 | 201.1026 | 0.0062 | 1 | 7 | negative regulation of erythrocyte differentiation |
| GO:0035270 | 0.0073 | 17.9954 | 0.1301 | 2 | 146 | endocrine system development |
| GO:0048469 | 0.0076 | 17.5045 | 0.1337 | 2 | 150 | cell maturation |
| GO:0019732 | 0.008 | 150.8077 | 0.008 | 1 | 9 | antifungal humoral response |
| GO:0060638 | 0.008 | 150.8077 | 0.008 | 1 | 9 | mesenchymal-epithelial cell signaling |
| GO:0072540 | 0.0089 | 134.0427 | 0.0089 | 1 | 10 | T-helper 17 cell lineage commitment |
| GO:0032660 | 0.0091 | 130.6 | 0.0091 | 1 | 11 | regulation of interleukin-17 production |
| GO:0010870 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | positive regulation of receptor biosynthetic process |
| GO:0032700 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | negative regulation of interleukin-17 production |
| GO:0033160 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | positive regulation of protein import into nucleus, translocation |
| GO:0034501 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | protein localization to kinetochore |
| GO:0045779 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | negative regulation of bone resorption |
| GO:0060484 | 0.0098 | 120.6308 | 0.0098 | 1 | 11 | lung-associated mesenchyme development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0046534 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of photoreceptor cell differentiation |
| GO:0061580 | 0.0011 | Inf | 0.0011 | 1 | 1 | colon epithelial cell migration |
| GO:0044027 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | hypermethylation of CpG island |
| GO:0045541 | 0.0057 | 230.6471 | 0.0057 | 1 | 5 | negative regulation of cholesterol biosynthetic process |
| GO:0032259 | 0.0068 | 8.9475 | 0.3965 | 3 | 346 | methylation |
| GO:0045347 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | negative regulation of MHC class II biosynthetic process |
| GO:0090241 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | negative regulation of histone H4 acetylation |
| GO:1902262 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | apoptotic process involved in patterning of blood vessels |
| GO:1902895 | 0.0091 | 131.7731 | 0.0092 | 1 | 8 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter |
| GO:0022617 | 0.0095 | 15.1953 | 0.149 | 2 | 130 | extracellular matrix disassembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060831 | 2e-04 | 128.9547 | 0.0203 | 2 | 11 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning |
| GO:0008052 | 0.0018 | Inf | 0.0018 | 1 | 1 | sensory organ boundary specification |
| GO:0060618 | 0.0018 | Inf | 0.0018 | 1 | 1 | nipple development |
| GO:0060649 | 0.0018 | Inf | 0.0018 | 1 | 1 | mammary gland bud elongation |
| GO:0060659 | 0.0018 | Inf | 0.0018 | 1 | 1 | nipple sheath formation |
| GO:1901731 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of platelet aggregation |
| GO:1990403 | 0.0018 | Inf | 0.0018 | 1 | 1 | embryonic brain development |
| GO:0060603 | 0.0022 | 32.1831 | 0.0702 | 2 | 38 | mammary gland duct morphogenesis |
| GO:0021532 | 0.0023 | 31.3113 | 0.072 | 2 | 39 | neural tube patterning |
| GO:0001709 | 0.0031 | 26.932 | 0.0831 | 2 | 45 | cell fate determination |
| GO:0006535 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | cysteine biosynthetic process from serine |
| GO:0007402 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | ganglion mother cell fate determination |
| GO:0010157 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | response to chlorate |
| GO:0021997 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | neural plate axis specification |
| GO:0035585 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | calcium-mediated signaling using extracellular calcium source |
| GO:0061193 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | taste bud development |
| GO:0070560 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | protein secretion by platelet |
| GO:1903887 | 0.0037 | 559.8571 | 0.0037 | 1 | 2 | motile primary cilium assembly |
| GO:0009957 | 0.0055 | 279.9107 | 0.0055 | 1 | 3 | epidermal cell fate specification |
| GO:0019343 | 0.0055 | 279.9107 | 0.0055 | 1 | 3 | cysteine biosynthetic process via cystathionine |
| GO:0042490 | 0.0062 | 18.6559 | 0.1182 | 2 | 64 | mechanoreceptor differentiation |
| GO:0008589 | 0.0066 | 18.0706 | 0.1219 | 2 | 66 | regulation of smoothened signaling pathway |
| GO:0010626 | 0.0074 | 186.5952 | 0.0074 | 1 | 4 | negative regulation of Schwann cell proliferation |
| GO:2001046 | 0.0074 | 186.5952 | 0.0074 | 1 | 4 | positive regulation of integrin-mediated signaling pathway |
| GO:0048865 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | stem cell fate commitment |
| GO:0060708 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | spongiotrophoblast differentiation |
| GO:0090315 | 0.0092 | 139.9375 | 0.0092 | 1 | 5 | negative regulation of protein targeting to membrane |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048149 | 1e-04 | 245 | 0.0115 | 2 | 10 | behavioral response to ethanol |
| GO:2000310 | 1e-04 | 150.7212 | 0.0172 | 2 | 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
| GO:0010811 | 2e-04 | 32.4833 | 0.1135 | 3 | 99 | positive regulation of cell-substrate adhesion |
| GO:0042755 | 6e-04 | 67.4957 | 0.0355 | 2 | 31 | eating behavior |
| GO:1900024 | 0.001 | 50.1571 | 0.047 | 2 | 41 | regulation of substrate adhesion-dependent cell spreading |
| GO:0021763 | 0.0011 | Inf | 0.0011 | 1 | 1 | subthalamic nucleus development |
| GO:0051460 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of corticotropin secretion |
| GO:0060127 | 0.0011 | Inf | 0.0011 | 1 | 1 | prolactin secreting cell differentiation |
| GO:0060578 | 0.0011 | Inf | 0.0011 | 1 | 1 | superior vena cava morphogenesis |
| GO:0060611 | 0.0011 | Inf | 0.0011 | 1 | 1 | mammary gland fat development |
| GO:0061358 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of Wnt protein secretion |
| GO:1900011 | 0.0011 | Inf | 0.0011 | 1 | 1 | negative regulation of corticotropin-releasing hormone receptor activity |
| GO:1902228 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of macrophage colony-stimulating factor signaling pathway |
| GO:1903971 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of response to macrophage colony-stimulating factor |
| GO:1904141 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of microglial cell migration |
| GO:1904209 | 0.0011 | Inf | 0.0011 | 1 | 1 | positive regulation of chemokine (C-C motif) ligand 2 secretion |
| GO:0007626 | 0.0013 | 16.2272 | 0.2223 | 3 | 194 | locomotory behavior |
| GO:0060443 | 0.0017 | 38.326 | 0.0607 | 2 | 53 | mammary gland morphogenesis |
| GO:0002432 | 0.0023 | 922.7647 | 0.0023 | 1 | 2 | granuloma formation |
| GO:0031635 | 0.0023 | 922.7647 | 0.0023 | 1 | 2 | adenylate cyclase-inhibiting opioid receptor signaling pathway |
| GO:0060460 | 0.0023 | 922.7647 | 0.0023 | 1 | 2 | left lung morphogenesis |
| GO:0060577 | 0.0023 | 922.7647 | 0.0023 | 1 | 2 | pulmonary vein morphogenesis |
| GO:1990523 | 0.0023 | 922.7647 | 0.0023 | 1 | 2 | bone regeneration |
| GO:0007215 | 0.0025 | 30.5156 | 0.0756 | 2 | 66 | glutamate receptor signaling pathway |
| GO:0003350 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | pulmonary myocardium development |
| GO:0035993 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | deltoid tuberosity development |
| GO:0042488 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | positive regulation of odontogenesis of dentin-containing tooth |
| GO:0061325 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | cell proliferation involved in outflow tract morphogenesis |
| GO:0071307 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | cellular response to vitamin K |
| GO:0071314 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | cellular response to cocaine |
| GO:1903972 | 0.0034 | 461.3529 | 0.0034 | 1 | 3 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:0001952 | 0.0045 | 22.6773 | 0.1009 | 2 | 88 | regulation of cell-matrix adhesion |
| GO:1903530 | 0.0045 | 7.0744 | 0.7025 | 4 | 613 | regulation of secretion by cell |
| GO:0002074 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | extraocular skeletal muscle development |
| GO:0002125 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | maternal aggressive behavior |
| GO:0003253 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021855 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | hypothalamus cell migration |
| GO:0032100 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | positive regulation of appetite |
| GO:0061031 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | endodermal digestive tract morphogenesis |
| GO:0071315 | 0.0046 | 307.549 | 0.0046 | 1 | 4 | cellular response to morphine |
| GO:0030155 | 0.0047 | 7.0144 | 0.7083 | 4 | 618 | regulation of cell adhesion |
| GO:0006954 | 0.005 | 6.8859 | 0.7209 | 4 | 629 | inflammatory response |
| GO:0060359 | 0.0052 | 20.961 | 0.1089 | 2 | 95 | response to ammonium ion |
| GO:0060126 | 0.0057 | 230.6471 | 0.0057 | 1 | 5 | somatotropin secreting cell differentiation |
| GO:0033273 | 0.0057 | 19.8852 | 0.1146 | 2 | 100 | response to vitamin |
| GO:0002158 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | osteoclast proliferation |
| GO:0045657 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | positive regulation of monocyte differentiation |
| GO:0055009 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | atrial cardiac muscle tissue morphogenesis |
| GO:0060763 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | mammary duct terminal end bud growth |
| GO:0097211 | 0.0069 | 184.5059 | 0.0069 | 1 | 6 | cellular response to gonadotropin-releasing hormone |
| GO:0097305 | 0.0076 | 8.5642 | 0.4137 | 3 | 361 | response to alcohol |
| GO:0035865 | 0.008 | 153.7451 | 0.008 | 1 | 7 | cellular response to potassium ion |
| GO:0043320 | 0.008 | 153.7451 | 0.008 | 1 | 7 | natural killer cell degranulation |
| GO:2000288 | 0.008 | 153.7451 | 0.008 | 1 | 7 | positive regulation of myoblast proliferation |
| GO:2000341 | 0.008 | 153.7451 | 0.008 | 1 | 7 | regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:0042476 | 0.0082 | 16.4936 | 0.1375 | 2 | 120 | odontogenesis |
| GO:0042117 | 0.0091 | 131.7731 | 0.0092 | 1 | 8 | monocyte activation |
| GO:0043951 | 0.0091 | 131.7731 | 0.0092 | 1 | 8 | negative regulation of cAMP-mediated signaling |
| GO:0061072 | 0.0091 | 131.7731 | 0.0092 | 1 | 8 | iris morphogenesis |
| GO:1903975 | 0.0091 | 131.7731 | 0.0092 | 1 | 8 | regulation of glial cell migration |
| GO:0034765 | 0.0097 | 7.8041 | 0.4527 | 3 | 395 | regulation of ion transmembrane transport |
| GO:0007399 | 0.0098 | 3.7577 | 2.6119 | 7 | 2279 | nervous system development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005298 | 0.001 | Inf | 0.001 | 1 | 1 | proline:sodium symporter activity |
| GO:0032440 | 0.001 | Inf | 0.001 | 1 | 1 | 2-alkenal reductase [NAD(P)] activity |
| GO:0036132 | 0.0019 | 1123.7857 | 0.0019 | 1 | 2 | 13-prostaglandin reductase activity |
| GO:0047522 | 0.0019 | 1123.7857 | 0.0019 | 1 | 2 | 15-oxoprostaglandin 13-oxidase activity |
| GO:0005232 | 0.0057 | 224.7 | 0.0057 | 1 | 6 | serotonin-activated cation-selective channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005157 | 0.0042 | 374.4048 | 0.0042 | 1 | 3 | macrophage colony-stimulating factor receptor binding |
| GO:0001601 | 0.0056 | 249.5873 | 0.0056 | 1 | 4 | peptide YY receptor activity |
| GO:0001602 | 0.0056 | 249.5873 | 0.0056 | 1 | 4 | pancreatic polypeptide receptor activity |
| GO:0042289 | 0.007 | 187.1786 | 0.007 | 1 | 5 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004062 | 0 | 413.7895 | 0.008 | 2 | 6 | aryl sulfotransferase activity |
| GO:0015035 | 4e-04 | 82.6737 | 0.0293 | 2 | 22 | protein disulfide oxidoreductase activity |
| GO:0001069 | 0.0013 | Inf | 0.0013 | 1 | 1 | regulatory region RNA binding |
| GO:1990631 | 0.0013 | Inf | 0.0013 | 1 | 1 | ErbB-4 class receptor binding |
| GO:0016667 | 0.0019 | 35.1198 | 0.0653 | 2 | 49 |